日本臨牀　69/増刊6　食道癌

出版社： 日本臨牀社
発行日： 2011-08-20
分野： 臨床医学：一般  >  雑誌
ISSN： 00471852
雑誌名：
特集： 食道癌―基礎・臨床研究の進歩―
電子書籍版： 2011-08-20 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

15,620 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

15,620 円(税込)

購入する

目次

  • 日本臨牀　69/増刊6　食道癌

    ―目次―

    特集　食道癌―基礎・臨床研究の進歩―

    I． 総　論 　 　
    　１． 食道癌診療の歴史と展望
    　２． 食道癌の解剖学的特性

    II． 食道癌の疫学 　 　
    　１． 我が国および世界における食道癌の罹患率と死亡率の動向
    　２．‘地域がん登録’に基づく食道癌登録の状況と課題
    　３． 食道扁平上皮癌のハイリスク群の設定

    III． 食道癌の分子生物学と発生機序 　 　
    　１． 食道癌の分子生物学
    　２． 食道癌の発生機序 　 　
    　３． Barrett食道癌の発生機序

    IV． 食道癌の病理 　 　
    　１． 食道癌病理学研究の進歩
    　２． 食道癌の病理学的分類 　 　

    V． 食道癌の病期(ステージ)分類とその問題点

    VI． 食道癌の「取扱い規約」と「診断・治療のガイドライン」
    　１． 食道癌取扱い規約改訂第10版の要点―病理学的立場から―
    　２．「食道癌診断・治療のガイドライン」改訂版
    　　　　　―欧米との比較― 　

    VII． 食道癌の診断 　 　
    　１． 癌の進行度診断とその困難性
    　２． 全身状態の評価
    　３． 食道造影検査(X線検査)
    　４． 内視鏡検査 　 　
    　５． 超音波内視鏡検査
    　６． CT・MRI検査
    　７． PET検査
    　８． 腫瘍マーカー、遺伝子診断
    　９． 中下咽頭癌の診断

    VIII． 食道癌の治療 　 　
    　1． 食道癌の治療戦略：概論 上野　正紀 205
    　2． 頸部食道癌の治療戦略
    　3． 胸部食道癌の治療戦略
    　4． 腹部食道癌の治療戦略
    　5． 内視鏡的治療 　 　
    　6． 外科治療 　 　
    　7． センチネルノードナビゲーションサージャリ― 　
    　8． 術前・術後補助療法　
    　9． 化学療法　
    　10． 放射線療法 　 　
    　11． 化学放射線療法
    　12． 化学放射線療法後のサルベージ手術
    　13． レーザー療法
    　14． 姑息的治療(ステント治療、バイパス手術)
    　15． 食道癌に対する遺伝子治療の現状と展望
    　16． 免疫療法、ワクチン療法
    　17． 食道癌治療後の経過観察法

    IX． 食道癌の再発とその治療 　 　
    　１． 内視鏡的切除後の再発
    　２． 食道癌根治術後の再発
    　３． 根治的化学放射線療法後の遺残再発

    X． 食道癌のQOL 　
    　１． 食道癌患者のための緩和ケア
    　２． クリニカルパスによる食道癌手術の管理 2
    　３． 食道癌の栄養管理
    　４ 喉頭摘出後の音声再建

    XI． 食道癌の多施設共同試験 　 　
    　１． 我が国における食道癌の多施設共同試験 　 　
    　２． 海外における食道癌の多施設共同試験

    XII． 特　論 　 　
    　１． 食道癌のインフォームドコンセント
    　２． 食道癌検診の現状と課題
    　３． DPC時代の食道癌治療の現状と課題
    　４． 食道癌内視鏡治療における医療経済への影響

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

序文

P.5 掲載の参考文献
1) Sakata R et al : Thoracic and cardiovascular surgery in Japan during 2008. Gen Thorac Cardiovasc Surg 58 : 356-383, 2010.
PubMed
2) 中山恒明 : 食道外科. 日外会誌 53 : 1-51, 1952.
 
3) 梅垣洋一郎 : 癌の放射線治療の基礎的及び臨床的研究. 中山恒明賞1993年受賞論文, p3-10, 財団法人中山がん研究所, 1994.
 
4) 木暮喬ほか : 新しい国産ファイバー食道鏡について. 胃と腸 1 : 577-580, 1966.
 
5) 多賀須幸男ほか : 細径ファイバースコープGIF-P2の上部消化管内視鏡としての有用性. 2500回の使用成績とこれからの消化管検査のありかたに関する一考察Gastroenterol Endosc 20 : 87-99, 1978.
 
6) 幕内博康ほか : 食道粘膜癌の内視鏡診断と治療. 消化器内視鏡 2 : 447-452, 1990.
 
7) 門馬久美子ほか : 食道粘膜癌の内視鏡的治療 ; 内視鏡的粘膜切除 (mucosectomy) を中心に. 消化器内視鏡 2 : 501-506, 1990.
 
8) Yokoyama A, et al : Multiple primary esophageal and concurrent upper aerodigestive tract cancer and the aldehyde dehydrogenase-2genotype of Japanese alcoholics. Cancer 77 : 1986-1990, 1996.
 
9) 井上晴洋ほか : NBI画像による咽頭・食道扁平上皮領域における内視鏡的異型度診断および内視鏡的深達度診断IPCLパターン分類. 日消誌 104 : 774-781, 2007.
 
10) 有馬美和子ほか : 早期食道癌深達度診断の進歩-FICE併用拡大内視鏡を中心に. 胃と腸 43 : 1489-1498, 2008.
 
11) 小山恒男ほか : 食道表在癌に対するEMR, 食道癌に対するEMRの選択方法 ; 新しいEMR手技-Hooking EMR methodの有用性. 臨牀消化器内科 16 : 1609-1615, 2001.
 

I 総論

P.15 掲載の参考文献
1) 第21回食道疾患研究会抄録集. 日消外会誌 10 (2) : 243-260, 1977.
 
2) 第40回食道疾患研究会抄録集. 日消外会誌 20 (8) : 2037-2061, 1987.
 
3) Comprehensive Registry of Esophageal Cancer in Japan, 2002, 2001, 1998 and 1999 (ed by the registration committee for esophageal cancer of The Japan Esophageal Society), 2010, 2009, 2002.
 
4) 中山恒明ほか : 食道早期癌の一例. 外科診療 8 : 1224-1226, 1966.
 
5) 山形敞一ほか : 主として細胞診によって診断された早期食道癌の一例. 胃と腸 1 (3) : 45-52, 1966.
 
6) Toriie S, et al : New trial for endoscopical observation of esophagus by dye scattering method. Endoscopy 7 : 75-79, 1975.
 
7) 佐野元哉ほか : ルゴール染色を利用した食道内視鏡検査法-食道癌の診断. 消化管の癌に対する色素内視鏡検査 (竹本忠良ほか編), p13-24, 医学図書出版, 1978.
 
8) 遠藤光夫 : 早期食道癌-全国集計の分析-. Gastroenterol Endosc 32 (10) : 2466-2470, 1990.
 
9) Kodama M : Treatment of superficial cancer of the esophagus : a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123 (4) : 432-439, 1998.
PubMed
10) 門馬久美子ほか : 食道粘膜癌の内視鏡治療-内視鏡的粘膜切除術 (mucosectomy) を中心に. 消化器内視鏡 2 : 501-506, 1990.
 
11) 幕内博康ほか : 食道粘膜癌に対する内視鏡的粘膜切除術の適応と限界. 日消外会誌 24 : 2599-2603, 1991.
 
12) Inoue H, et al : A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC). Surg Endosc 6 : 264-265, 1992.
PubMed
13) Hanashi T, et al : Clinical evaluation on treatments for mucosal cancer of the esophagus. In : Disease of the Esophagus (ed by Peracchia A, et al), p203-207, Monduzzi Editore, Bologna, 1996.
 
14) 日本食道疾患研究会 (編) : 食道癌治療ガイドライン2002年12月版, 金原出版, 2002.
 
15) 遠藤光夫, 河野辰幸 : 食道表在癌肉眼分類の新しい提案. 胃と腸 22 (12) : 1343-1348, 1987.
 
16) 日本食道疾患研究会 (編) : 食道癌取扱い規約, 第8版, 金原出版, 1992.
 
17) 幕内博康ほか : 食道m3・sm1癌の治療成績 胃と腸 37 (1) : 53-63, 2002.
 
18) 小山恒男ほか : 第46回食道色素研究会アンケート調査報告-転移のあったm3・sm1食道癌の特徴. 胃と腸 37 (1) : 71-74, 2002.
 
19) 吉田操ほか : 食道癌の深達度診断-内視鏡像からみた深達度診断. 胃と腸 36 (3) : 295-306, 2001.
 
20) 日本食道学会 (編) : 食道癌取扱い規約, 第10版, 金原出版, 2008.
 
21) 横山顕ほか : 中・下咽頭領域の表在癌の危険因子. 胃と腸 45 (2) : 180-189, 2010.
 
22) 三木一正 : 胃がんスクリーニングのハイストラテジーに関する研究. 厚生労働科学研究補助金第3次対がん総合戦略研究事業 胃がんスクリーニングのハイストラテジーに関する研究 平成17年度総括・分担報告書, p142-154, 2006.
 
23) 吉野邦俊 : 中・下咽頭癌の疫学・臨床統計. 胃と腸 40 (9) : 1229-1238, 2005.
 
24) Igaki H, et al : A randomized trial of postoperative adjuvant chemotherapy versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of esophagus. J Clin Oncol 26 : ASCO Meeting Proceedings Supplement 4510, 2008.
 
25) 室圭ほか : 食道sm2/sm3癌に対する放射線・化学療法の治療成績-clinical stage I食道癌に対する放射線・化学療法について-. 胃と腸 37 (10) : 1305-1314, 2002.
 
26) Minashi K, et al : A phase II study of chemoradiotherapy in patients with stage II, III esophageal squamous cell carcinoma : JCOG trial (JCOG9906). Proc. Gastrointestinal Cancer Symposium : 129, 2008.
 
P.28 掲載の参考文献
1) Nagel A : Die Bindegewebsgeruest des menschlichen Oesophagus in seinen funktionell Beziehungen zur glatten Muskulatur und den Blutgefassen. Morph Jahrb 81 : 449-492, 1938.
 
2) Gunter S, Lierse W : Die Angioarchitektur im Oesophagus des Kaninchen, der Ratte und der Maus. Ergebn Anat Entwickl-gesch 40 : 1-23, 1968.
 
3) 馬場政道ほか : 胸部食道癌に対する縦隔の層構造からみた神経切除と温存. 手術 48 : 1123-1130, 1994.
 
4) 佐藤達夫 : 肺癌・食道癌手術に必要な縦隔の局所解剖 (ビデオ), 私家版, 1995.
 
5) Lerche W : The Esophagus and Pharynx in Action, p 24, Charles Thomas, Springfiield, 1956.
 
6) 高橋大八郎 : 気管支動脈の肉眼解剖学的研究とその臨床的意義. 弘前医学 42 : 230-242, 1990.
 
7) 佐藤達夫 : 胸部の地図帳, pp 66-81, 講談社, 東京, 2008.
 
8) 舟波裕ほか : 食道癌手術視野からみた気管支動脈の走行に対する解剖学的検討. 日外会誌 94 : 456-465, 1993.
 
9) Greving R : Die Innervation der Speiserohre, Z angewandten Anat Konstitutionlehre 5 : 327-357, 1920.
 
10) 佐藤達夫, 坂本裕和 : リハビリテーション解剖アトラス, pp 52-55, 医歯薬出版, 東京, 2006.
 
11) 佐藤達夫 : リンパ節解剖カラーフォトアトラス, 1. 縦隔のリンパ節. 手術 57 : 1203-1210, 2003.
 
12) 佐藤達夫 : 気管・食道のリンパ系の局所解剖. 日気食会報 50 : 227-234, 1999.
 
13) 佐藤達夫 : 消化器の局所解剖学-食道・胃, pp 1-144, 金原出版, 東京, 1993.
 

II 食道癌の疫学

P.35 掲載の参考文献
1) 人口動態統計 (厚生労働省大臣官房統計情報部編).
 
2) 財団法人がん研究振興財団 : がんの統計 '10.
 
3) Zendehdel K : Risk indicators for esophageal cancer : Some medical conditions and tobacco-related factors. Karolinska Institutet, 2007.
 
4) Malhado RE, et al : The changing face of esophageal cancer. Cancer 2 : 1379-1404, 2010.
 
P.40 掲載の参考文献
1) 食道癌取扱い規約 (日本食道学会編), 金原出版, 2008.
 
2) 食道癌診断・治療ガイドライン (日本食道学会編), 金原出版, 2008.
 
3) Ozawa S, et al : Comprehensive Registry of Esophageal Cancer in Japan, 2003. Esophagus 8 : 9-29, 2011.
 
4) http://www.jacr.info/about/registry.html
 
5) http://www.jacr.info/map.html
 
6) Matsuda T, et al ; The Japan Cancer Surveillance Research Group : Cancer incidence and incidence rates in Japan in 2005 : based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 41 : 139-147, 2011.
 
7) 総務省統計局 : 平成22年国勢調査人口速報集計結果, 2011.
 
8) 地域がん登録全国協議会 : 地域がん登録の手引き改訂第5版, 2007.
 
9) http://www.jncdb.org/jes/Esophagus_Top.html
 
P.47 掲載の参考文献
1) 大森泰ほか : 集検による食道癌の早期診断. 食道表在癌画像診断と病理, p58-69, 医学書院, 1993.
 
2) Takezaki T, et al : Subsite-specific risk factors for hypopharyngeal and esophageal cancer (Japan). Cancer Causes Control 11 : 597-608, 2000.
PubMed
3) 幕内博康ほか : 食道癌手術症例にみられる他臓器重複癌. EMR症例を含めて. 胃と腸 38 : 317-330, 2003.
 
4) Ishihara R, et al : Prospective evaluation of narrow-band imaging endoscopy for screening of esophageal squamous mocosal high-grade neoplasia in experienced and less experienced endoscopists. Dis Esophagus 23 : 480-486, 2010.
 
5) Shimizu Y, et al : Metachronous squamous cell carcinoma of the esophagus arising after endoscopic mucosal resection. Gastrointest Endosc 54 : 190-194, 2001.
PubMed
6) Muto M, et al : Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region. Carcinogenesis 26 : 1008-1012, 2005.
PubMed
7) 横山顕ほか : 大酒家における食道表在癌内視鏡切除後の2次癌. 胃と腸 42 : 1365-1374, 2007.
 
8) Yokoyama A, et al : Alcohol and aldehyde dehydrogenase polymorphisms and a new strategy for prevention and screening for cancer in the upper aerodigestive tract in East Asians. Keio J Med 59 : 115-130, 2010.
 
9) 西隆之ほか : 食道メラノーシスと食道癌. 日気管食道会報 56 : 221, 2005.
 
10) Yamaji T, et al : Fruit and vegetable consumption and squamous cell carcinoma of the esophagus in Japan : the JPHC study. Int J Cancer 123 : 1935-1940, 2008.
PubMed
11) Rehm J, et al : Alcohol drinking cessation and its effect on esophageal and head and neck cancers : A pooled analysis. Int J Cancer 121 : 1132-1137, 2007.
PubMed
12) Yang SJ, et al : Relationship between genetic polymorphisms of aldehyde dehydrogenase-2 and alcohol dehydrogenase-1B and esophageal cancer risk : A meta-analysis. Wbrld J Gastroenterol 16 : 4210-4220, 2010.
 
13) Secretan B, et al : A review of human carcinogens-Part E : tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10 : 1033-1034, 2009.
PubMed
14) Yokoyama A, et al : Health risk appraisal models for mass screening for esophageal and pharyngeal cancer : an endoscopic follow-up study of cancer-free Japanese men. Cancer Epidemiol Biomarkers Prev 18 : 651-655, 2009.
PubMed
15) Tanaka F, et al : Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADHIB and/or ALDH2 risk alleles. Gut 59 : 1457-1464, 2010.
PubMed

III 食道癌の分子生物学と発生機序

P.56 掲載の参考文献
1) International Human Genome Sequence Consortium : Finishing the euchromatic sequence of the human genome. Nature 431 : 931-945, 2004.
 
2) Pao W, et a1 : EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101 : 13306-13311, 2004.
 
3) Allegra CJ, et al : American Society of Clinical Oncology provisional clinical opinion : testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 27 (12) : 2091-2096, 2009.
 
4) Song C, et al : Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61 (8) : 3272-3275, 2001.
 
5) Research Committee of Malignancy of Esophageal Cancer, Japanese Society for Esophageal Diseases : Prognostic significance of cyclin D1 and E-cadherin in patients with esophageal squamous cell carcinoma : multiinstitutional retrospective analysis. J Am Coll Surg 192 (6) : 708-718, 2001.
 
6) Shiozaki H, et al : Clinical signhicance of immunohistochemically detected lymph node micrometastasis in patients with histologically node-negative esophageal carcinoma : a multi-institutional study. Esophagus 4 (1) : 35-39, 2007.
 
P.61 掲載の参考文献
1) 食道疾患研究会 (編) : 臨床・病理 食道癌取扱い規約, 第8版, p24, 金原出版, 1992.
 
2) WHO International Histological Classification of Tumours, Histological Typing of Oesophageal and Gastric Tumours (ed by Watanabe H, et al), second ed, Springer-Verlag, Berlin Heidelberg, 1990,
 
3) Schlemper RJ, et al : Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and western pathologists. Cancer 88 : 996-1006, 2000.
PubMed
4) 板橋正幸ほか : 食道癌の病理-最近の進歩と話題. 臨牀消化器内科増刊号 15 (7) : 46-54, 2000.
 
5) Endo M, et al : Early cancer of the esophagus : diagnosis and clinical evaluation. Int Adv Surg Oncol 3 : 49-71, 1980.
PubMed
6) 吉井由利ほか : 食道粘膜癌のアンケート調査による症例解析. Gastroenterol Endosc 35 : 2516-2524, 1993.
 
7) 小玉正智, 掛川暉夫 : 食道表在癌の治療-第49回食道疾患研究会, 食道表在癌アンケート集計報告. 日外会誌 97 : 683-690, 1996.
 
8) 吉田操, 井出博子 : 早期食道癌の診断と治療. 日気食会報 39 : 145-150, 1988.
 
9) 海上雅光ほか : 病理からみた局所治療の適応. 食道表在癌-画像診断と病理 (吉田操ほか編), p151-159, 医学書院1993.
 
10) 門馬久美子ほか : 食道粘膜癌の内視鏡診断-深達度亜分類を用いた深達度診断の検討. 胃と腸 29 : 327-340, 1994.
 
11) Makuuchi H : Endoscopic mucosal resection for early esophageal cancer-Indication and techniques. Dig Endosc 8 : 175-179, 1996.
 
12) 渡辺英伸ほか : m3・sm1食道扁平上皮癌の病理. 胃と腸 33 : 985-992, 1998.
 
13) 遠藤光夫ほか : 「早期食道癌の内視鏡治療」どのようなものが適応となるのか. 消化器診療プラクティス15胃癌・食道癌の内視鏡治療 (中村孝司ほか編), p139-142, 文光堂, 1998.
 
14) 有馬美和子ほか : 早期食道深達度診断の進歩-FICE併用拡大内視鏡を中心に-. 胃と腸 43 : 1489-1498, 2008.
 
15) 井上晴洋ほか : 早期食道深達度診断の進歩-NBI拡大内視鏡を中心に-. 胃と腸 43 : 1479-1488, 2008.
 
16) 島田英雄ほか : 食道表在癌の深達度診断-通常観察の立場から-. 胃と腸 45 : 1467-1481, 2010.
 
17) 藤原純子ほか : 食道表在癌の深達度診断-通常内視鏡の立場から-. 胃と腸 45 : 1483-1495, 2010.
 
18) Gabbert HE, et al : Squamous cell carcinoma of the esophagus. In : World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System (ed by Hamilton SR Aaltonen LA), p 11-19, IARC, Lyon, 2000.
 
19) Schlemper RJ, et al : The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47 : 251-255, 2000.
PubMed
P.66 掲載の参考文献
1) Hanahan D, Weinberg RA : The hallmarks of cancer. Cell 100 (1) : 57-70, 2000.
PubMed
2) Rosenberg C, et al : Spectrum of genetic changes in gastro-esophageal cancer cell lines determined by an integrated molecular cytogenetic approach. Cancer Genet Cytogenet 135 : 35-41, 2002.
PubMed
3) Ishizuka T, et al : Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH, Biochem Biophys Res Commun 296 : 152-155, 2002.
PubMed
4) Sugimoto T, et al : Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer. Oncol Rep 18 : 465 -472, 2007.
 
5) Hirasaki S, et al : BAC clones related to prognosis in patients with esophageal squamous carcinoma : an array comparative genomic hybridization study. Oncologist 12 : 406-417, 2007.
PubMed
6) Akagi I, et al : SnoN overexpression in predictive of poor survival in patients with esophageal squamous cell carcinoma. Ann Surg Oncol 15 : 2965, 2009.
 
7) Sugimoto T, et al : The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma. Genes Chromosomes Cancer 48 : 132-142, 2009.
PubMed
8) Lai LA, et al : Deletion at fragile site is a common and early event in Barrrett's esophagus. Mol Cancer Res 8 : 1084-1094, 2010.
 
9) He L, et al : A microRNA polycistron as a potential human oncogene. Nature 435 : 828-833, 2005.
PubMed
10) Feber A, et al : MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 135 (2) : 255-260, 2008.
PubMed
11) Guo Y, et al : Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68 (1) : 26-33, 2008.
PubMed
12) Kan T, et al : The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 136 (5) : 1689-1700, 2009.
PubMed
13) Luthra R, et al : MicroRNA-196a targets annexin A1 : a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 27 (52) : 6667-6678, 2008.
PubMed
14) Hiyoshi Y, et al : MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 15 (6) : 1915-1922, 2009.
PubMed
15) Mathe EA, et al : MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus : associations with survival. Clin Cancer Res 15 (19) : 6192-6200, 2009.
 
16) Zhang H, et al : Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 55 (9) : 2545-2551, 2010.
PubMed
17) Tian Y, et al : MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J Biol Chem 285 (11) : 7986-7994, 2010.
PubMed
18) Kano M, et al : miR-145, miR-133a and miR-133b : Tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127 (12) : 2804-2814, 2010.
PubMed
19) Kimura S, et al : Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus : miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep 23 (6) : 1625-1633, 2010.
PubMed
20) Hong L, et al : The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 251 (6) : 1056-1063, 2010.
PubMed
21) Moustakas A, Heldin CH : Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98 (10) : 1512-1520, 2007.
PubMed
22) Natsuizaka M, et al : Insulin-like growth factor-binding protein-3 promotes transforming growth factor-｛beta｝1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells. Carcinogenesis 31 (8) : 1344-1353, 2010.
PubMed
23) LaGamba DA, et al : Microarray analysis of gene expression during epithelial-mesenchymal transformation. Dev Dyn 234 (1) : 132-142, 2005.
 
24) Kitamura, et al : SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nat Genet 39 (4) : 467-475, 2007.
PubMed
25) Kaplan, et al : VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (7069) : 820-827, 2005.
PubMed
26) Noma K, et al : The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 134 (7) : 1981-1993, 2008.
PubMed
27) Grugan KD, et al : Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci USA 107 (24) : 11026-11031, 2010.
 
P.73 掲載の参考文献
1) Spechler SJ, Goyal RK : Barrett's esophagus. N Engl J Med 315 : 362-371, 1986.
PubMed
2) Colleypriest BJ, et al : How does innammation cause Barrett's metaplasia? Curr Opin Pharmacol 9 : 721-726, 2009.
 
3) Reid BJ, et al : Barrett's oesophagus and oesophageal adenocarcinoma : time for a new synthesis. Nat Rev Cancer 10 : 87-101, 2010.
PubMed
4) Devesa SS, et al : Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 : 2049 -2053, 1998.
 
5) Pohl H, Welch HG : The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 : 142-146, 2005.
PubMed
6) 日本食道学会 (編) : 臨床・病理 食道癌取扱い規約 (第10版補訂版), 金原出版, 2008.
 
7) Sampliner RE : Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameter Committee of the American College of Gastroenterology. Am J Gastroenterol 93 : 1028-1032, 1998.
PubMed
8) Armstrong D : Review article : Towards consistency in the endoscopic diagnosis of Barrett's esophagus and columnar metaplasia. Aliment Pharmacol Ther 20 (Suppl 5) : 40-47, 2004.
 
9) Amano Y, et al : Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric fold or the palisade vessels? Gastrointest Endosc 64 : 206-211, 2006.
PubMed
10) Lieberman DA, et al : Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 92 : 1293-1297, 1997.
PubMed
11) Romero Y, et al : Barrett's esophagus : prevalence in symptomatic relatives. Am J Gastroenterol 97 : 1127-1132, 2002.
PubMed
12) Fass R, et al : Correlation of oesophageal acid exposure with Barrett's oesophagus length. Gut 48 : 310-313, 2001.
PubMed
13) Okita K, et al : Barrett's esophagus in Japanese patients : its prevalence, form and elongation. J Gastroenterol 43 : 928-934, 2008.
PubMed
14) Moriyama N, et al : Localization of early-stage dysplastic Barrett's lesions in patients with shortsegment Barrett's esophagus. Am J Gastroenterol 101 : 2666-2667, 2006.
 
15) Katsube T, et al : Difference in localization of esophageal mucosal breaks among grades of esophagitis. J Gastroenterol Hepatol 21 : 1656-1659, 2006.
PubMed
16) Kinoshita Y, et al : Asymmetrical circumferential distribution of esophagogastric junctional lesions : anatomical and physiological considerations. J Gastroenterol 44 : 812-818, 2009.
PubMed
17) Vaezi MF, Richter JE : Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 111 : 1192-1199, 1996.
PubMed
18) Nehra D, et al : Toxic bile acids in gastro-esophageal reflux disease : influence of gastric acidity. Gut 44 : 598-602, 1999.
PubMed
19) Kaur BS, et al : Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion. Am J Physiol Gastrointest Liver Physiol 283 : G327-G334, 2000.
 
20) Cook MB, et al : A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol 162 : 1050-1061, 2005.
PubMed
21) Hampel H, et al : Meta-analysis : obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143 : 199-211, 2005.
PubMed
22) Smith KJ, et al : Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14 : 2481-2486, 2005.
PubMed
23) Vaezi MF, Richter JE : Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 117 : 699-704, 1995.
PubMed
24) Kauer WK, et al : Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgery therapy re-emphasized. Ann Surg 222 : 525-533, 1995.
 
25) Miwa K, et al : Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67 : 269-274, 1996.
 
26) Souza RF, et al : Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 122 : 299-307, 2002.
PubMed
27) Kahrilas PJ : Review article : is stringent control of gastric pH useful and practical in GERD? Aliment Pharmacol Ther 20 (Suppl 5) : 89-94, 2004.
 
28) Guo RJ, et al : The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther 3 : 593-601, 2004.
PubMed
29) James R, et al : Structure of the murine homeobox gene cdx-2. Expression in embryonic and adult intestinal epithelium. J Biol Chem 269 : 15229-15237, 1994.
PubMed
30) Silberg DG, et al : Cdx1 protein expression in norma1, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology 113 : 478-486, 1997.
 
31) Eda A, et al : Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol 38 : 14-22, 2003.
 
32) Eda A, et al : Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol 37 : 94-100, 2002.
PubMed
33) Mutoh H, et al : Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun 294 : 470-479, 2002.
PubMed
34) Mutoh H, et al : Development of gastric carcinoma from intestinal metaplasia in Cdx-2 transgenic mice. Cancer Res 64 : 7740-7747, 2004.
 
35) Mutoh H, et al : Cdx1 induced intestinal metaplasia in the transgenic mouse stomach : comparative study with Cdx2 transgenic mice. Gut 53 : 1416-1423, 2004.
PubMed
36) Phillips RW, et al : Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol 27 : 1442-1447, 2003.
PubMed
37) Kazumori H, et al : Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium. Gut 55 : 16-25, 2006.
 
38) Kazumori H, et al : Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development. Gut 58 : 620-628, 2009.
 
39) Mesquita P, et al : Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines. J Biol Chem 278 : 51549-51556, 2003.
PubMed
40) van Wering HM, et al : Novel interaction at the Cdx-2 binding sites of the lactase-phlorizin hydrolase promoter. Biochem Biophys Res Commun 299 : 587-593, 2002.
PubMed
41) Di Guglielmo MD, et al : Nucleotide requirements for Cdx2 binding to the cis promoter element mediating intestine-specific expression of guanylyl cyclase C. FEBS Lett 507 : 128-132, 2001.
 
42) Debruyne PR, et al : Bile acids induce ectopic expression of intestinal guanylyl cyclase C through nuclear factor-kappa B and Cdx2 in human esophageal cells. Gastroenterology 130 : 1191-1206, 2006.
PubMed
43) Alkhoury F, et al : Differential regulation of intestinal alkaline phosphatase gene expression by Cdx1 and Cdx2. Am J Physiol Gastrointest Liver Physiol 289 : G285-G290, 2005.
PubMed
44) Sharma P, et al : A critical review of the diagnosis and management of Barrett's esophagus : the AGA Chicago Workshop. Gastroenterology 127 : 310-330, 2004.
 
45) Hage M, et al : Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol 39 : 1175-1179, 2004.
PubMed
46) 河野辰幸ほか : 日本人のBarrett粘膜の頻度Gastroenterol Endosc 47 : 951-961, 2008.
 
47) 服部隆則ほか : 基礎研究の進歩, パレット食道の発生機序-ラット十二指腸液逆流モデルからの知見-. 日本臨牀 63 : 1341-1349, 2005.
 
48) Dedeoglu F, et al : Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NF-κB. Int Immunol 16 : 395-404, 2004.
 
49) Morisawa T, et al : Organ-specific profiles of genetic changes in cancers caused by activationinduced cytidine deaminase expression. Int J Cancer 123 : 2735-2740, 2008.
PubMed
50) Okazaki IM, et al : Constitutive expression of AID leads to tumorigenesis. J Exp Med 197 : 1173-1181, 2003.
PubMed
51) McColl KE : When saliva meets acid : chemical warfare at the oesophagogastric junction. Gut 54 : 1-3, 2005.
PubMed
52) Suzuki H, et al : Conditions for acid catalysed luminal nitrosation are maximal at the gastric cardia. Gut 52 : 1095-1101, 2003.
PubMed
53) Suzuki H, et al : Nitrate and nitrosative chemistry within Barrett's oesophagus during acid reflux. Gut 54 : 1527-1535, 2005.
PubMed

IV 食道癌の病理

P.83 掲載の参考文献
1) 吉田操 : 食道表在癌の診療. 胃と腸 46 : 528-530, 2011.
 
2) 中山恒明ほか : 食道早期癌の一例. 外科診療 8 : 1224-1226, 1966.
 
3) 山形敞一ほか : 主として細胞診によって診断された早期食道癌の1例. 胃と腸 1 : 259-266, 1966.
 
4) 食道疾患研究会 (編) : 食道癌取扱い規約, 第7版, 金原出版, 1989.
 
5) 板橋正幸ほか : 表在食道癌の病理学的診断-肉眼的および組織学的診断と問題点. 胃と腸 20 : 1293-1302, 1985.
 
6) 渡辺英伸ほか : 病理からみた早期食道癌の定義と肉眼診断. 胃と腸 25 : 1075-1086, 1990.
 
7) 吉田操ほか : 食道m, sm癌の質的診断ならびに鑑別診断. 胃と腸 25 : 1059-1066, 1990.
 
8) 井手博子ほか : 表在性食道癌肉眼分類の新しい提案. 胃と腸 22 : 1369-1376, 1987.
 
9) 幕内博康ほか : 内視鏡による食道m癌, sm癌の質的診断と鑑別診断. 胃と腸 25 : 1051-1058, 1990.
 
10) 海上雅光ほか : 肉眼像からみた食道表在癌の深達度の読み方. 胃と腸 27 : 139-155, 1992.
 
11) 白壁彦夫 : 食道粘膜癌の臨床的意義. 胃と腸 29 : 259-261, 1994.
 
12) 日本食道学会 (編) : 食道癌取扱い規約, 第10版補訂版, 金原出版, 2009.
 
13) 細井董三ほか : 早期食道癌のX線学的深達度診断-m癌とsm癌の鑑別を中心に. 胃と腸 25 : 1039-1050, 1990.
 
14) 大倉康男ほか : 食道粘膜癌の病型分類と深達度. 胃と腸 29 : 263-271, 1994.
 
15) 小玉正智, 掛川暉夫 : 食道表在癌の治療-第49回食道疾患研究会, 食道表在癌アンケート集計報告. 日外会誌 97 : 683-690, 1996.
 
16) 渡辺英伸ほか : m3・sm1食道扁平上皮癌の病理. 胃と腸 33 : 985-992, 1998.
 
17) Endo M, et al : Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 13 : 125-129, 2000.
PubMed
18) 小山恒男ほか : 第46回食道色素研究会アンケート調査報告-転移のあったm3・sm1食道癌の特徴. 胃と腸 37 : 71-74, 2002.
 
19) Egashira H, et al : Predictive factors for lymph node metastasis in esophageal squamous cell carcinomas containing or penetrating the muscularis mucosae : the utility of droplet infiltration. Esophagus 3 : 47-52, 2006.
 
20) 藤田昌宏ほか : 治療成績からみた食道m3・sm癌の治療方針. 胃と腸 41 : 1407-1415, 2006.
 
21) 立石陽子ほか : 切除標本の病理診断-特に追加治療の判断材料としての病理診断. 胃と腸 46 : 579-586, 2011.
 
22) 門馬久美子ほか : 食道癌に対する内視鏡的粘膜切除 (strip biopsy) の検討. 日消外会誌 22 : 2918, 1989.
 
23) 井上晴洋ほか : 内視鏡的食道粘膜広範囲切除術 (extensive EMRT). Progress of Digestive Endoscopy (消化器内視鏡の進歩) 36 : 168-171, 1990.
 
24) 幕内博康ほか : 食道粘膜癌に対する内視鏡的粘膜切除術の適応と限界および食道領域のEndoscopic Surgery. 日消外会誌 22 : 2918, 1989.
 
25) Natsugoe S, et al : Snail plays a key role in E-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep 17 : 517-523, 2007.
 
26) Chiba T, et al : Independent histological risk factors for lymph node metastasis of superficial esophageal carcinoma ; implication of claudin-5 immunohistochemistry for expanding the indications of endoscopic resection. Dis Esophagus 23 : 398-407, 2010.
PubMed
27) Takubo K, et al : Early squamous cell carcinoma of the oesophagus : the Japanese viewpoint. Histopathology 51 : 733-742, 2007.
PubMed
28) 中村恭一ほか : 早期食道癌の病理組織学的所見-その診断と発育・進展について. 胃と腸 20 : 1275-1284, 1985.
 
29) Kobayashi M, et al : p53 mutation analysis of low-grade dysplasia and high-grade dysplasia/carcinoma in situ of the esophagus using laser capture microdissection. Oncology 71 : 237-245, 2006.
PubMed
30) 大倉康男 : 食道表在癌の病理診断, dysplasiaとintraepithelial neoplasia. 胃と腸 46 : 587-591, 2011.
 
31) 佐野元哉ほか : ルゴール染色を利用した食道内視鏡検査法-食道癌の診断. 消化管の癌に対する色素内視鏡検査 (竹本忠良ほか編), p 13-24, 医学図書出版, 1978.
 
32) 吉田操ほか : 食道多発癌の内視鏡診断 (とくにトルイジンブルー・ヨードニ重染色法の応用について). 日消外会誌 13 : 367-368, 1980.
 
33) 川村徹ほか : ヨード不染帯の臨床的意義 病理切除標本の立場から. 胃と腸 29 : 875-882, 1994.
 
34) Inoue H : Magnification endoscopy in the esophagus and stomach. Dig Endosc 13 : S40-41, 2001.
 
35) Arima M, et al : Evaluation of microvascular patterns of superficial esophageal cancers by magnifying endoscopy. Esophagus 2 : 191-197, 2005.
 
36) Kumagai Y, et al : Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture of superficial esophageal carcinoma. Endoscopy 34 : 369-375, 2002.
PubMed
37) 根本哲生ほか : 食道・咽頭表層血管 (IPCL) の変化と病理組織像の対比. 病理と臨床 28 : 576-584, 2010.
Medical*Online
38) Kumagai Y, et al : Magnifying chromoendoscopy of the esophagus : in-vivo pathological diagnosis using an endocytoscopy system. Endoscopy 36 : 590-594, 2004.
PubMed
39) Inoue H, et al : Endoscopic in vivo evaluation of tissue atypia in the esophagus using a newly designed integrated endocytoscope : a pilot study. Endoscopy 38 : 891-895, 2006.
PubMed
40) 幕内博康ほか : 食道癌手術症例にみられる他臓器重複癌-EMR症例を含めて. 胃と腸 38 : 317-330, 2003.
 
41) 横山顕 : 食道表在癌の危険因子. 胃と腸 46 : 561-570, 2011.
 
42) Fujii S, et al : Microvascular irregularities are associated with composition of squamous epithelial lesion and correlate with subepithelial invasion of superficial type pharyngeal squamous cell carcinoma. Histopathology 56 : 510-522, 2010.
PubMed
43) Ohashi K, et al : Superficial basaloid squamous carcinoma of the esophagus. A clinicopathological and immunohistochemical study of 12 cases. Pathol Res Pract 199 : 713-721, 2003.
PubMed
44) Kobayashi Y, et al : Histological diversity in basaloid squamous cell carcinoma of the esophagus. Dis Esophagus 22 : 231-238, 2009.
PubMed
45) Takubo K, et al : Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol 40 : 65-74, 2009.
PubMed
46) Takubo K, et al : Differences in the definitions used for esophageal and gastric diseases in different countries : endoscopic definition of the esophagogastric junction, the precursor of Barrett's adenocarcinoma, the definition of Barrett's esophagus, and histologic criteria for mucosal adenocarcinoma or high-grade dysplasia. Digestion 80 : 248-257, 2009.
PubMed
P.92 掲載の参考文献
1) 日本食道学会 (編) : 食道癌取扱い規約, 10版補訂版, 金原出版, 2008.
 
2) WHO Classification of Tumours of the Digestive System (ed by Bosman FT, et al), 4th ed, International Agency for Research on Cancer, Lyon, 2010.
 
3) 日本食道学会 (編) : 食道癌診断・治療ガイドライン, 2007年4月版, 金原出版, 2007.
 
4) Egashira H, Yanagisawa A : Predictive factors for lymph node metastasis in esophageal squamous cell carcinomas contacting or penetrating the muscularis mucosae : the utility of droplet infiltration. Esophagus 3 : 47-52, 2006.
 
5) 加藤洋ほか : 食道における癌とdysplasiaの鑑別の基準. 胃と腸 20 : 1303-1309, 1985.
 
P.98 掲載の参考文献
1) Seremetis MG, et al : Leiomyoma of the esophagus. A report of 19 surgical cases. Ann Thorac Surg 16 : 308-316, 1973.
 
2) 田久保海誉ほか : 食道平滑筋腫について. 日消外会誌 13 : 668, 1980.
 
3) 島津久明ほか : 食道平滑筋腫と平滑筋肉腫-自験9例の報告と本邦文献上報告例の分析-. 日外会誌 84 : 355-368, 1983.
 
4) Miettinen M, et al : Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs) : a review. Eur J Cancer 38 : S39-S51, 2002.
PubMed
5) Miettinen M, et al : Esophageal stromal tumors : a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 24 : 211-222, 2000.
PubMed
6) Arai T, et al : Benign schwannoma of the esophagus : report of two cases with immunohistochemical and ultrastructural studies. Pathol Int 44 : 460-465, 1994.
PubMed
7) Saito R, et al : Esophageal schwannoma. Ann Thorac Surg 69 : 1947-1949, 2000.
PubMed
8) Kobayashi N, et al : Benign esophageal schwannoma : report of a case. Surg Today 30 : 526-529, 2000.
PubMed
9) Chen HC, et al : Esophageal schwannoma with tracheal compression. Thorac Cardiovasc Surg 54 : 555-558, 2006.
PubMed
10) Murase K, et al : Malignant schwannoma of the esophagus with lymph node metastasis : literature review of schwannoma of the esophagus. J Gastroenterol 36 : 772-777, 2001.
PubMed
11) 細井広子ほか : 内視鏡的に切除し得た食道顆粒細胞腫の1例と本邦報告例の文献的検討. 消化器内視鏡 3 : 821-826, 1991.
 
12) Sanchez AA, et al : Comparison of primary and metastatic malignant melanoma of the esophagus : clinicopathologic review of 10 cases. Arch Pathol Lab Med 132 : 1623-1629, 2008.
PubMed
13) Sabljak P, et al : Primary esophageal diffuse large B-cell lymphoma : report of a case. Surg Today 38 : 647-650, 2008.
PubMed
14) Hosaka S, et al : A case of primary low grade mucosa associated lymphoid tissue (MALT) lymphoma of the oesophagus. Gut 51 : 281-284, 2002.
PubMed

V 食道癌の病期 ( ステージ ) 分類とその問題点

P.106 掲載の参考文献
1) 日本食道学会 (編) : 食道癌取扱い規約, 第10版補訂版, 金原出版, 2008.
 
2) International Union Against Cancer : TNM Classification of Malignant Tumours, 7th ed, Wiley-Blackwell, 2009.
 
3) American Joint Committee on Cancer : Cancer Staging Manual, 7th ed, Springer, New York, 2010.
 
4) Nishimaki T, et al : Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 186 : 306-312, 1998.
PubMed
5) Matsubara T, et al : Better grading systems for evaluating the degree of lymph node invasion in cancer of the thoracic esophagus. Surg Today 24 : 500-505, 1994.
PubMed
6) 安田卓司ほか : 食道癌治療 最近の動向 2. 進行度診断. 日外会誌 109 : 3-9, 2008.
 
7) Vallboehmer D, et al : A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg 252 : 744-749, 2010.
 

VI 食道癌の「取扱い規約」と「診断・治療のガイドライン」

P.120 掲載の参考文献
1) 日本食道学会 (編) : 臨床・病理 食道癌取扱い規約, 第10版, 2008年, 金原出版.
 
2) Gabbert HE, et al : Squamous cell carcinoma of the esophagus. In : WHO Classification of Tumors : Pathology and Genetics of Tumors of the Digestive System (ed by Hamilton H and Aaltonen L), P11-19, IARC, Lyon, 2000.
 
3) Montgomery E, et al : Squamous cell carcinoma of the esophagus. In : WHO Classification of Tumors of the Digestive System (ed by Bosman F, et al), p 1824-1819, IARC, Lyon, 2010.
 
4) Schlemper RJ, et al : The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47 : 251-255, 2000.
PubMed
5) Schlemper RJ, et al : Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologist. Cancer 88 : 996-1006, 2000.
PubMed
6) 石黒信吾ほか : 追跡例からみた食道異形成 (dysplasia) -第33回食道色素研究会「食道異形成 (dysplasia) を考える」のまとめを中心に. 胃と腸 31 : 695-704, 1996.
 
7) 大倉康男 : 食道癌取扱い規約に定義された上皮内腫瘍の病理組織学的検討-食道小扁平上皮癌と上皮内腫瘍. 胃と腸 44 : 1735-1740, 2009.
 
8) 八尾隆史ほか : 食道上皮内扁平上皮癌とintraepithelial neoplasiaの鑑別. 胃と腸 44 : 1741-1748, 2009.
 
9) Rindi G, et al : Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In : WHO Classification of Tumors of the Digestive System (ed by Bosman F, et al), p 13-14, IARC, Lyon, 2010.
 
10) 谷瑞希ほか : 病理学的にみた日本人胃癌の時代的変遷. 胃と腸 40 : 27-36, 2005.
 
11) Kusano C, et al : Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol 23 : 1662-1665, 2008.
 
12) Siewert JR, Stein HJ : Carcinoma of the cardia : carcinoma of the gastroesophageal junctionclassification, pathology and extent of resection. Dis Esophagus 9 : 173-182, 1996.
 
13) Siewert JR, Stein HJ : Classification of adenocarcioma of the esophagogastric junction. Br J Surg 85 : 1457-1459, 1998.
 
14) Sobin L, et al : Oesophagus including Oesophagogastric Junction. In : TNM Classification of Malignant Tumours, 7th ed, p 66-69, UICC, Wiley Blackwell, 2009.
 
15) Nakanishi Y, et al : Distribution and significance of the oesophageal and gastric cardiac mucosae : a study of 131 operation specimens. Histopathology 51 : 515-519, 2007.
PubMed
16) Takubo K, et al : Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol 40 : 65-74, 2009.
PubMed
17) Wang KK, Sampliner RE : Updated guidelines 2008 for the diagnosis, surveillance and therapy for Barrett's esophagus. Am J Gastroenterol 103 : 788-797, 2008.
PubMed
18) Odze RD : Barrett esophagus : histology and pathology for clinician. Nat Rev Gastroenterol Hepatol 6 : 478-490, 2009.
PubMed
19) Robert H, et al : Definition of Barrett's esophagus : time for a rethink-Is intestinal metaplasia dead? Am J Gastroenterol 104 : 2588-2594, 2009.
 
20) Nunobe S, et al : Two distinct pathways of tumorigenesis of adenocarcinomas of the esophagogastric junction, related or unrelated to intestinal metaplasia. Pathol Int 57 : 315-321, 2007.
PubMed
P.125 掲載の参考文献
1) 日本食道疾患研究会 (編) : 食道癌治療ガイドライン, 金原出版, 2002.
 
2) 加藤広行ほか : 食道癌ガイドライン. 外科治療 94 : 123-133, 2006.
 
3) 日本食道学会 (編) : 食道癌診断・治療ガイドライン2007年4月版, 金原出版, 2007.
 
4) 安藤暢敏ほか : わが国における食道癌集学的治療の歩み. 癌と化学療法 37 : 1674-1678, 2010.
Medical*Online

VII 食道癌の診断

P.132 掲載の参考文献
1) Nishimaki T, et al : Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer. Ann Thorac Surg 68 : 2059-2064, 1999.
PubMed
2) 藤原純子ほか : 食道表在癌の深達度診断 通常内視鏡の立場から. 胃と腸 45 : 1483-1495, 2010.
 
3) 島田英雄ほか : 食道表在癌の深達度診断 通常観察の立場から. 胃と腸 45 : 1467-1481, 2010.
 
4) Igaki H, et a1 : Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 20 : 1089-1094, 2001.
 
5) Arima M, et al : Diagnostic accuracy of tumor staging and treatment outcomes in patients with superficial esophageal cancer. Esophagus 4 : 145-153, 2007.
 
6) Igaki H, et al : A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for localized squamous cell carcinoma of the thoracic esophagus (JCOG9907). Proc Am Clin Oncol 26 : Abstr 4510, 2008.
 
7) 奥田逸子ほか : 食道癌の診断-CT, MRI. 消化器外科 27 : 33-42, 2004.
 
8) 安田卓司ほか : 進行度診断. 日外会誌 109 : 3-9, 2008.
 
P.136 掲載の参考文献
1) 食道癌診断・治療ガイドライン (日本食道学会編), 金原出版, 2007.
 
2) 竹内裕也ほか : 高齢者消化器外科手術における併存疾患管理. 外科 72 (3) : 229-233, 2010.
 
3) Kohn RR : Human aging and diseases. J Chronic Dis 16 : 5-12, 1963.
PubMed
4) Oken MM, et al : Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 : 649-655, 1982.
 
5) Saito T, et al : Prediction of operative mortality based on impairment of host defense systems in patients with esophageal cancer. J Surg Oncol 52 : 1-8, 1993.
PubMed
6) 桑野博行ほか : 食道癌の術'前検査および処置の原則. 食道外科の要点と盲点, p 128-129, 中山書店, 2003.
 
7) Copeland GP, et al : POSSUM : a scoring system for surgical audit. Br J Surg 78 : 355-360, 1991.
PubMed
8) Vacanti CJ, et al : A statistical analysis of the relationship of physical status to postoperative mortality in 68, 388 cases. Anesth Analg 49 : 564-566, 1970.
 
9) Haga Y, et al : Prediction of anastomotic leak and its prognosis in digestive surgery. World J Surg 35 : 716-722, 2011.
PubMed
10) Akutsu Y, Matsubara H : Perioperative management for the prevention of postoperative pneumonia with esophageal surgery. Ann Thorac Cardiovasc Surg 15 (5) : 280-285, 2009.
PubMed
11) Theadom A, Cropley M : Effect of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers : asystematic review. Tob Control 15 : 352-358, 2006.
 
12) Thomas JA, McIntosh JM : Are incentive spirometry, intermittent positive pressure breathing, and deep breathing exercises effective in the prevention of postoperative pulmonary complications after upper abdominal surgery? A systemic overview and meta-analysis. Phys Ther 74 : 3-16, 1994.
 
13) Olsen ME et al : Randomized controlled trial of prophylactic chest physiotherapy in major abdominal surgery. Br J Surg 84 : 1535-1538, 1997.
 
14) Akutsu Y, et al : Pre-operative dental brushing can reduce the risk of postoperative pneumonia in esophageal cancer patients. Surgery 147 (4) : 497-502, 2010.
PubMed
15) Baigrie RJ, et al : Enteral versus parenteral nutrition after esophagogastric surgery : a prospective randomized comparison. Aust N Z J Surg 66 : 668-670, 1996.
PubMed
16) Takagi K, et al : Modulating effects of the feeding route on stress response and endotoxin translocation in severely stressed patients receiving thoracic esophagectomy. Nutrition 16 : 355 -360, 2000.
 
P.140 掲載の参考文献
1) 植松貞夫ほか : 食道癌のX線診断. 臨床消化器内科 2 : 563-572, 1987.
 
2) 飯沼元ほか : Digital radiographyによる消化管造影検査の検討. 映像情報 Medical 1996.
Medical*Online
3) 杉野吉則ほか : FPDと消化管診断. 臨床放射線 52 : 1309-1315, 2007.
 
4) 小田丈二ほか : 食道表在癌のX線診断. 臨床消化器内科 25 : 469-779, 2010.
 
P.149 掲載の参考文献
1) 日本食道学会 (編) : 臨床・病理-食道癌取扱い規約, 10版, 金原出版, 2007.
 
2) 門馬久美子ほか : 食道表在癌深達度診断 (通常観察). 消化器内視鏡 18 : 674-679, 2006.
 
3) 日本食道疾患研究会 (編) : 食道癌治療ガイドライン, p35, 金原出版, 2002.
 
4) 門馬久美子ほか : 食道m3・sm1癌の質的・量的内視鏡診断. 胃と腸 37 : 33-46, 2002.
 
5) 有馬美和子ほか : 表在食道癌の微細血管像による深達度診断. 消化器内視鏡 17 : 2076-2083, 2005.
 
P.155 掲載の参考文献
1) Tajiri H, Niwa H : 電子内視鏡の最近の進歩 : 画像強調内視鏡 (Recent Advances in Electronic Endoscopes : Image-enhanced endoscopy). JMAJ 51 (3) : 199-203, 2008.
 
2) 有馬美和子ほか : 食道表在癌の深達度診断-FICE拡大内視鏡の立場から. 胃と腸 45 (9) : 1515-1525, 2010.
 
3) 有馬美和子ほか : 内視鏡と病理との接点 (第1回), 食道表在癌の拡大内視鏡診断における病理との接点. 病理と臨床 28 (10) : 1082」087, 2010.
 
4) Muto M, et al : Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging : a multicenter randomized controlled trial. J Clin Oncol 28 (9) : 1566-1572, 2010.
PubMed
5) Katada C, et al : Narrow band imaging for detecting superficial squamous cell carcinoma of the head and neck in patients with esophageal squamous cell carcinoma. Endoscopy 42 (3) : 185-190, 2010.
PubMed
6) 井上晴洋ほか : 血管パターン分類からみた食道粘膜の性状診断. 消化器内視鏡 17 (12) : 2069-2075, 2005.
 
7) 南ひとみほか : 食道表在癌の深達度診断-NBI拡大内視鏡の立場から. 胃と腸 45 (9) : 1496-1503, 2010.
 
8) 南ひとみほか : 消化管拡大内視鏡の最前線-咽頭・食道-アンケートパッド 食道扁平上皮癌の内視鏡的異型度診断 IPCL type IIIとIPCL type IVを中心に. Gastroenterol Endosc 51 (Suppl 2) : 2046, 2009.
 
9) Shimizu Y, et al : Endoscopic diagnosis of early squamous neoplasia of the esophagus with iodine staining : high-grade intra-epithelial neoplasia turns pink within a few minutes. J Gastroenterol Hepatol 23 (4) : 546-550, 2008.
PubMed
10) 大森泰ほか : ヨード不染帯診断におけるPink Color signの臨床的有用性の検討. 慶應医学 80 (2) : 52, 2003.
 
11) 有馬美和子ほか : 早期食道癌深達度診断の進歩-Fice併用拡大内視鏡を中心に. 胃と腸 43 (10) : 1489-1498, 2008.
 
P.161 掲載の参考文献
1) Falk GW, et al : Practice pattern for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 49 : 170-176, 2000.
 
2) 日本食道学会 (編) : 食道癌取扱い規約, 第10版, 金原出版, 2008.
 
3) Takubo K, et al : Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma. Hum Pathol 40 : 65-74, 2009.
PubMed
4) Sharma P, et al : The development and validation of an endoscopic grading system for Barrett's esophagus : the Prague C & Mcriteria. Gastroenterology 131 : 1392-1399, 2006.
 
5) Canto MI, et al : Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 44 : 1-7, 1996.
PubMed
6) Sharma P, et al : Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gut 52 : 24-27, 2003.
PubMed
7) Endo T, et al : Classification of Barrett's epithelium by magnifying endoscopy. Gastrointest Endosc 55 : 641-647, 2002.
 
8) Goda K, et al : Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar-lined esophagus and Barrett's adenocarcinoma. Gastrointest Endosc 65 : 36-46, 2007.
 
9) Muto M, et al : Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging : a multicenter randomized controlled trial. J Clin Oncol 28 : 1566-1572, 2010.
PubMed
10) 小山恒男ほか : Barrett食道癌の境界を読む. 胃と腸 39 : 1243-1249, 2004.
 
11) 小山恒男ほか : Barrett食道およびBarrett食道癌の拡大観察. 臨牀消化器内科 21 : 407-413, 2006.
 
12) 小山恒男ほか : Barrett食道癌の拡大内視鏡診断. 胃と腸 42 : 691-695, 2007.
 
13) 小山恒男 : 拡大内視鏡による胃癌診断. ESDのための胃癌術前診断 (小山恒男編), p43-59, 南江堂, 2010.
 
14) 小山恒男 : NBIによるBarrett食道表在癌の内視鏡像. 内視鏡診断のプロセスと疾患別内視鏡像 (長南明道ほか編), p331-333, 日本メディカルセンター, 2009.
 
15) Bollschweiler E, et al : High rate of lymph-node metastasis in submucosal esophageal squamouscell carcinomas and adenocarcinomas. Endoscopy 38 : 149-156, 2006.
PubMed
P.168 掲載の参考文献
1) Kudo S, et al : Depressed type of colorectal cancer. Endoscopy 27 : 54-57, 1995.
PubMed
2) Inoue H, et al : Ultra-high magnification endoscopy of the normal esophageal mucosa. Dig Endosc 8 : 134-138, 1996.
 
3) Inoue H, et al : Ultra-high magnification endoscopic observation of carcinoma in situ of the esophagus. Dig Endosc 9 : 16-18, 1997.
 
4) Yao K, et al : Novel magnified endoscopic findings of microvascular architecture in intramucosal gastric cancer. Gastrointest Endosc 56 : 279-284, 2002.
PubMed
5) 山形敬一, 三浦清美 : 内視鏡検査に対するテレビジョンならびに体腔顕微鏡の応用について. 日消誌 60 : 909-918, 1963.
 
6) 丹羽寛文 : 直腸立体拡大観察と色素法-炎症性腸疾患について. 臨床消化器内科 7 : 275-278, 1992.
 
7) Lawrence AY : Fluorescein angiography complication survey. Ophthalmology 93 : 611-617, 1986.
 
8) Inoue H, et al : A novel method of virtual histopathology using laser-scanning confocal microscopy in vitro untreated fresh specimens from the gastrointestinal mucosa. Endoscopy 32 : 439-443, 2000.
PubMed
9) Dickensheets DL, Kino GS : Micromachined scanning confocal optical microscope. Opt Lett 21 : 764-767, 1996.
PubMed
10) Inoue H, et al : Development of virtual histology and virtual biopsy using laser scanning confocal microscopy. Scand J Gastroenterol 38 : 37-39, 2003.
 
11) Sakashita M, et al : Virtual histology of colorectal lesions using laser-scanning confocal microscopy. Endoscopy 35 : 1033-1038, 2003.
PubMed
12) Delaney PM, et al : Fiber-optic laser scanning confocal microscope suitable for fluorescence imaging. Appl Opt 33 : 573-577, 1994.
PubMed
13) Kiesslich R, et al : Confocal laser endoscopy for diagnosing intraepithelial neoplasia and colorectal cancer in vivo. Gastroenterology 127 : 706-713, 2004.
PubMed
14) Hamou J : Microhysteroscopy. Acta Endoscopica 10 : 415-422, 1980.
 
15) Tada M, et al : A new method for the ultra-magnifying observation of the colon mucosa. Kyoto Pref Univ Med 91 : 349-354, 1982.
 
16) Andrea M, et al : Contact endoscopy of the vocal cord : normal and pathological patterns. Acta Otolaryngol 115 : 314-316, 1995.
PubMed
17) 大植雅之 : Contact Endoscopyを用いた大腸癌の術中リアルタイム診断第37回日本癌治療学会総会, 岐阜, 1999年10月12-14日.
 
18) 熊谷洋一 : Contact Endoscopyを用いた食道表在癌の観察, 色素法併用による基礎検討. 第57回日本食道学会学術集会, 2003年6月27-28日.
 
19) 井上晴洋ほか : 生体内での生きた癌細胞の観察, Endo-Cytoscopy system. 医学のあゆみ 207 : 942-943, 2003.
Medical*Online
20) Kumagai Y, et al : Magnifying chromoendoscopy of the esophagus : in vivo pathological diagnosis using an endocytoscopy system. Endoscopy 36 : 590-594, 2004.
PubMed
21) Inoue H, et al : In vivo observation of living cancer cells in the esophagus, stomach, and colon using catheter-type contact endoscpe, "endocytoscopy system". Gastrointest Endosc Clin N Am 14 : 589-594, 2004.
PubMed
22) Inoue H, et al : Technology insight : laser-scanning confocal microscopy and endocytoscopy for cellular observation of the gastrointestinal tract, Nat Clin Pract Gastroenterol Hepatol 2 : 31-37, 2005.
PubMed
23) Inoue H, et al : Endoscopic in vivo evaluation of tissue atypia in the esophagus using a newly designed integrated endocytoscope : a pilot trial. Endoscopy 38 : 891-895, 2006.
PubMed
24) 井上晴洋ほか : 超・拡大内視鏡-エンドサイトにおける「CM2重染色」の開発と安全性について-. 日本臨牀 68 (7) : 1247-1252, 2010.
 
25) 井上晴洋ほか : Endocytoscopy : 技術概説. 消化器内視鏡 21 : 251-256, 2009.
Medical*Online
P.173 掲載の参考文献
1) 山中桓夫 : コンセンサスミーティングのプロダクツ1-EUS壁構造の解釈. Gastroenterol Endosc 1091-1092, 2001.
 
2) 有馬美和子, 多田正弘 : 高周波数細径超音波プローブによる食道表在癌の深達度を誤認させる要因と画像の特徴. 胃と腸 39 : 901-913, 2004.
 
3) 有馬美和子ほか : 食道癌の病期診断におけるEUSの精度. 消化器内視鏡 14 : 573-581, 2002.
 
4) 有馬美和子 : 術前内視鏡診断. 超音波内視鏡1. 食道. 食道・胃・十二指腸診断 (川尻久雄. 小山恒男編), p138-148, 羊土社, 2009.
 
5) 有馬美和子, 多田正弘 : EUS-FNABによる縦隔・食道疾患の診断. 消化器内視鏡 20 : 599-606, 2008.
 
P.181 掲載の参考文献
1) 土岐祐一郎ほか : T4食道癌の画像診断とそれに基づく治療選択. 外科治療 85 : 78-88, 2001.
Medical*Online
2) Botet JF, et al : Preoperative staging of esophageal cancer : comparison of endoscopic US and dynamic CT. Radiology 181 : 419-425, 1991.
PubMed
3) Picus D, et al : Computed tomography in the staging of esophageal carcinoma. Radiology 146 : 433-438, 1983.
PubMed
4) Quint LE, et al : Esophageal carcinoma : CT findings. Radiology 155 : 171-175, 1985.
PubMed
5) 岡住慎一ほか : US, CT, MRIを使った診断 (精密検査) と治療効果の判定 食道 悪性腫瘍 (深達度・転移). 胃と腸 34 : 295-301, 1999.
 
6) 古川敬芳 : MRIによる食道癌他臓器浸潤診断に関する研究. 日外会誌 92 : 636-644, 1991.
 
7) 岡住慎一ほか : CT・MRIによる食道癌の病期診断臨床放射線 52 : 1394-1402, 2007.
 
8) 幕内博康 : 食道粘膜癌の内視鏡的治療. 新外科学大系 消化管の外科, p43-55, 中山書店, 1996.
 
9) 鶴丸昌彦 : 進行食道癌3領域リンパ郭清の適応. 食道外科の要点と盲点, p146-152, 文光堂, 2003.
 
10) 奥田逸子ほか : 食道癌の診断 CT, MRI. 消化器外科 27 : 33-39, 2004.
 
11) Mizowaki T, et al : Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer : evaluation by computed tomography and magnetic resonance imaging. Int J Radiat Oncol Biol Phys 36 : 1091-1098, 1996.
PubMed
12) 松木充ほか : CT, MRIによる消化器癌リンパ節の画像診断Radiology Frontier 9 : 261-269, 2006.
 
13) Sakurada A, et al : Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 19 : 1461-1469, 2009.
 
14) Hayashi H, et al : CT lymphography-navigated sentinel lymph node biopsy in patients with superficial esophageal cancer. Surgery 139 : 224-235, 2006.
PubMed
15) Ishiyama K, et al : Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer. J Comput Assist Tomogr 30 : 270-275, 2006.
PubMed
16) Nishimura H, et al : Preoperative esophageal cancer staging : magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. J Am Coll Surg 202 : 604-611, 2006.
PubMed
17) 日本食道学会 (編) : 食道癌取扱い規約第10版補訂版, 金原出版, 2008.
 
P.187 掲載の参考文献
1) 加藤広行ほか : FDG-PET検査による消化器癌の診断. 日消誌 101 : 1292-1301, 2004.
Medical*Online
2) 加藤広行ほか : 消化器癌診断におけるFDG-PETの有用性. Annual review消化器 (戸田剛太郎ほか編), p1-10, 中外医学社, 2005.
 
3) 織内昇ほか : PET. 消化器外科学レビュー2005 最新主要文献と解説 (門田狩人ほか監), p 178-182, 総合医学社, 2005.
 
4) Kato H, et al : Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Anticancer Res 23 : 3263-3272, 2003.
PubMed
5) Inoue T, et al : Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology. Nucl Med Commun 20 : 849-857, 1999.
PubMed
6) Kato H, et al : Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 94 : 921-928, 2002.
PubMed
7) Kato H, et al : The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 103 : 148-156, 2005.
PubMed
8) Kato H, et al : Positron emission tomography in esophageal cancer. Esophagus 2 : 111-121, 2005.
 
9) 加藤広行ほか : 食道癌の診断と治療 FDG-PET. 消化器外科 27 : 43-52, 2004.
 
10) 加藤広行, 桑野博行 : 消化器腫瘍治療におけるPETの実際-食道腫瘍を中心に-. 癌治療と宿主 15 : 135-144, 2003.
Medical*Online
11) 加藤広行ほか : 各種疾患とPET, 食道疾患. 臨床医 31 : 1597-1602, 2005.
 
12) 加藤広行ほか : III臨床. 第3章 食道癌. クリニカルPETハンドブック (鳥塚莞爾ほか編), p 164-175, 技術経済研究所, 2001.
 
13) 加藤広行ほか : PETと消化器疾患, 食道癌におけるFDG-PET検査. GI Research 14 : 437-444, 2006.
 
14) Himeno S, et al : Evaluation of esophageal cancer by positron emission tomography. Jpn J Clin Oncol 32 : 340-346, 2002.
PubMed
15) 安田卓司ほか : 外科領域におけるPETの意義と臨床応用-食道癌-. 外科 68 (6) : 627-635, 2006.
 
16) van Westreenen HL, et al : Systemic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 22 : 3805-3812, 2004.
 
17) Flamen P, et al : Utility of positron emission tomography for staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18 : 3202-3210, 2000.
PubMed
18) van Westreenen HL, et al : Positron emission tomography with 18F-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 9 : 54-61, 2005.
 
19) Kato H, et al : Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg 91 : 1004-1009, 2004.
PubMed
20) 加藤広行ほか : 再発食道癌に対する最新の画像診断. 臨床外科 60 : 161-167, 2005.
 
21) Flamen P, et al : The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 120 : 1085-1092, 2000.
PubMed
22) Kato H, et al : Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer. Am J Surg 184 : 279-283, 2002.
PubMed
23) Wieder HA, et al : Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction. J Nucl Med 46 : 2029-2034, 2005.
PubMed
24) Koike I, et al : FDG-PET scanning after radiation can predict tumor regrowth three month later. Int J Radiat Oncol Biol Phys 57 : 1231-1238, 2003.
PubMed
25) Duong CP, et al : FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancer. Eur J Nucl Med Mol Imaging 33 : 770-778, 2006.
PubMed
P.194 掲載の参考文献
1) Kato H, Torigoe T : Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 40 : 1621-1628, 1977.
PubMed
2) Gold P, Freedman SO : Demonstration of tumor-specific antigens in human colonic carcinoma by immunological tolerance and absorption techniques. J Exp Med 121 : 439-462, 1965.
PubMed
3) Benchimol S, et al : Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57 : 327-334, 1989.
PubMed
4) Moll R et al : The catalog of human cytokeratins : pattems of expression in normal epithelia, tumors and cultured cells. Cell 31 : 11-24, 1982.
 
5) 島田英昭ほか : 血清p53抗体-診断とモニタリング-. 日本臨牀 68 (増刊号7) : 829-832, 2010.
Medical*Online
6) Shimada H, et al : Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer 89 : 1677-1683, 2000.
PubMed
7) Shimada H, et al : Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma. Surgery 132 : 41-47, 2002.
PubMed
8) Makino T, et al : p53 mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer. Ann Surg Oncol 17 : 804-811, 2010.
PubMed
9) Ozawa S, et al : Prognostic significance of EGF receptor in esophageal squamous cell carcinomas. Cancer 63 : 2169-2173, 1989.
PubMed
10) Inada S, et al : Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). Surg Today 29 : 493-503, 1999.
 
11) Takeuchi T, et al : Altered p16/MTS1/CDKN2/and cyclin D1/PRAD-1 gene expression is associated with prognosis of squamous cell carcinoma of the esophagus. Clin Cancer Res 3 : 2229-2236, 1997.
 
12) Ikeda G, et al : Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus. Cancer 86 : 1396-1405, 1999.
PubMed
13) Sturm I, et al : Analysis of p53/BAX/p16 (ink4a/CDKN2) in esophageal squamous cell carcinoma : high BAX and p16 (ink4a/CDKN2) identifies patients with good prognosis. J Clin Oncol 19 : 2272-2281, 2001.
 
14) Nakashima S, et al : Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma. Anticancer Res 20 : 1933 -1937, 2000.
 
15) Takayama T, et al : Bcl-X expression in esophageal squamous cell carcinoma : association with tumor progression and prognosis. J Surg Oncol 78 : 116-123, 2001.
PubMed
16) Ikeguchi M, et al : Bax expression as a prognostic marker of postoperative chemotherapy for patients with esophageal cancer. Int J Mol Med 7 : 413-417, 2001.
PubMed
17) Kato J, et al : Expression of survivin in esophageal cancer : correlation with the prognosis and response to chemotherapy. Int J Cancer 95 : 92-95, 2001.
PubMed
18) Kleespies A, et al : Vascular endothelial growth factor in esophageal cancer. J Surg Oncol 87 : 95-104, 2004.
PubMed
19) Barclay C, et al : Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin Cancer Res 11 : 7683-7691, 2005.
PubMed
20) Krishnadath KK, et al : Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182 : 331-338, 1997.
PubMed
21) Sharma R, et al : Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer. Oncology 67 : 300-309, 2004.
PubMed
22) Uchikado Y, et al : Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma. Int J Oncol 29 : 1337-1347, 2006.
PubMed
23) Feber A, et al : MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 135 : 255-260, 2008.
PubMed
P.202 掲載の参考文献
1) Slaughter DP, et al : Field cancerization in oral stratified squamous epithelium : clinical implications of multicentric origin. Cancer 6 : 963-968, 1953.
PubMed
2) Yokoyama A, et al : Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19 : 1383-1387, 1998.
 
3) Yokoyama A, et al : Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn J Clin Oncol 33 : 111-121, 2003.
PubMed
4) 横山顕ほか : 大酒家における扁平上皮癌におけるアルコール代謝酵素の関連からみた多発癌および口腔咽喉と胃の多臓器重複癌. 胃と腸 38 : 339-348, 2003.
 
5) 川久保博文ほか : 中・下咽頭癌の長期予後. 胃と腸 45 (2) : 265-281, 2010.
 
6) 川久保博文ほか : 見落とさない中下咽頭観察法. 消化器内視鏡 22 (6) : 915-923, 2010.
Medical*Online
7) 横山顕ほか : Field cancerizationとしての頭頸部・食道の表在癌. JOHNS 25 : 157-162, 2009.
Medical*Online
8) 幕内博康ほか : 食道癌手術症例にみられる他臓器重複癌, EMR症例を含めて. 胃と腸 38 : 317-330, 2003.
 
9) Watanabe A, et al : The value of narrow band imaging endoscope for early head and neck cancers. Otolaryngol Head Neck Surg 138 : 446-451, 2008.
PubMed
10) Yokoyama A, et al : Risk of squamous cell carcinoma of the upper aerodigestive tract in cancer-free alcoholic Japanese men : an endoscopic follow-up study. Cancer Epidemiol Biomarkers Prev 13 : 67-72, 2006.
PubMed
11) 横山顕ほか : 中・下咽頭領域の表在癌の危険因子-アルコール依存症男性の内視鏡検診に基づく症例対照研究. 胃と腸 45 : 180-189, 2010.
 
12) 横山顕ほか : 大酒家における食道表在癌内視鏡切除後の2次癌. 癌のない大酒家の長期経過との比較. 胃と腸 42 : 1365-1374, 2007.
 
13) 頭頸部癌取扱い規約 (日本頭頸部癌学会編), 4版, 金原出版, 2005.
 

VIII 食道癌の治療

P.211 掲載の参考文献
1) 人口動態統計 (厚生労働省大臣官房統計情報部編). (http://ganjoho.ncc.go.jp/public/statistics/)
 
2) 日本胸部外科学会 : 2008年学術調査結果. (www.jpats.org/)
 
3) The Japanese Society for Esophageal Diseases : Comprehensive Registry of Esophageal Cancer in Japan, 3rd ed, 2002.
 
4) Akiyama H, et al : Systemic lymph node dissection for esophageal cancer-effective or not? Dis Esophagus 7 : 2-13, 1994.
 
5) JCOG Study. (http://www.jcog.jp/basic/clinicaltrial/index.html)
 
6) 日本食道学会 (編) : 食道癌診断・治療ガイドライン, 2007年4月版. 金原出版, 2007.
 
7) 布袋屋修, 矢作直久 : 上部消化管腫瘍に対する内視鏡治療の進歩, 日本臨牀 68 (7) : 1290-1294, 2010.
Medical*Online
8) 宇田川晴司 : 欧米との比較から見た日本の食道癌治療技術レベルと, 外科治療の役割. 外保連ニュース 11 : 3-4, 2009.
 
9) Kato H, et al : Phase II Study of Chemoradiotheraphy with 5-Fluorouracil and Cisplatin for Stage II-III Esophageal Squamous Cell Carcinoma : JCOG Trial (JCOG9906). Int J Radiat Oncol Biol Phys. (in press)
 
10) Igaki H, et al : A Randomized trial of postoperative adjuvant chemotheraphy with cisplatin and 5-fluorouracil versus neoadjuvant chemotheraphy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG9907). J Clin Oncol 26 (May 20 Suppl) : abstr 4510, 2008.
 
11) Minsky BD, et al : INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer : high-dose versus standard-dose radiation therapy. J Clin Oncol 20 (5) : 1167-1174, 2002.
PubMed
12) International Union Against Cancer : TNM Classification of Malignant Tumors (ed by Sobin LH, et al), 7th ed, Wiley-Blackwell, Oxford, 2009.
 
13) Hulscher JB, et al : Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 : 1662-1669, 2002.
PubMed
14) 日本内視鏡外科学会 : 内視鏡外科手術に関するアンケート調査-第10回集計結果報告 . 日鏡外会誌 15 (5) : 565-679, 2010.
 
15) 宇田川晴司ほか : 開胸手術と胸腔鏡手術-食道癌根治術精緻化にむけて. 手術 63 (13) : 1883-1887, 2009.
 
P.216 掲載の参考文献
1) 日本食道学会 (編) : 食道癌診断・治療ガイドライン2007年4月版, 金原出版, 2007.
 
2) Peracchia A, et al : Current status of surgery for carcinoma of the hypopharynx and cervical esophagus. Dis Esophagus 14 : 95-97, 2001.
PubMed
3) 佐藤道夫, 安藤暢敏 : 頸部食道癌の手術. 消化器外科 27 : 53-57, 2004.
 
4) 安田卓司ほか : 頸部食道癌-根治性と喉頭温存の限界への挑戦-. 日気食会報 57 : 120-124, 2006.
 
5) 赤羽誉ほか : 当科における頸部食道癌の手術経験. 日気食会報 57 : 125-129, 2006.
 
6) Ott K, et al : Limited resection and free jejunal graft interposition for squamous cell carcinoma of the cervical oesophagus. Br J Surg 96 : 258-266, 2009.
PubMed
7) Swisher SG, et al : Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123 : 175-183, 2002.
PubMed
8) Tachimori Y, et al : Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137 : 49-54, 2009.
PubMed
9) Miyata H, et al : Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol 100 : 442-446, 2009.
PubMed
10) 中村努ほか : 進行頸部食道癌に対する根治的化学放射線療法の治療成績. 日気食会報 59 : 115-119, 2008.
 
11) 宇田川晴司ほか : 下咽頭食道癌サルベージ手術の諸問題とその対策. 日気食会報 61 : 107-109, 2010.
 
12) Hitt R, et al : Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23 : 8636-8645, 2005.
PubMed
13) Vermorken JB, et al : Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 : 1695-1704, 2007.
PubMed
14) Posner MR, et al : Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 : 1705-1715, 2007.
 
15) Ajani JA, et al : Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus : RTOG 0113. J Clin Oncol 26 : 4551-4556, 2008.
PubMed
P.221 掲載の参考文献
1) 日本食道学会 (編) : 食道癌取扱い規約, 第10版, 金原出版, 2007.
 
2) 日本食道学会 (編) : 食道癌診断・治療ガイドライン, 金原出版, 2007.
 
3) 松原久裕 : 内視鏡治療にて残存が疑われる場合. 早期食道癌 (桑野博行編), 中外医学社, 2011. (in press)
 
4) 幕内博康ほか : 食道扁平上皮癌に対する内視鏡切除術の適応. 胃と腸 44 : 311 -324, 2009.
 
5) Matsubara H : Salvage surgery for esophageal carcinoma after definitive chemoradiation therapy. Ann Thorac Cardiovasc Surg 13 : 293-295, 2007.
PubMed
6) Isono K, et al : Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 48 : 411-420, 1991.
 
7) The Registration Committee for Esophageal Cancer : Comprehensive registry of esophageal cancer in Japan (The Japan Esophageal Society), 2003.
 
8) Igaki H, et al : Arandomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG9907). J Clin Oncol 26 (Suppl) : Abstr 4510, 2008.
 
9) Gebski V, et al : Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma : a meta-analysis. Lancet Oncol 8 : 226-234, 2007.
 
10) Akutsu Y, et al : Clinical and pathologic evaluation of the effectiveness of neoadjuvant chemoradiation therapy in advanced esophageal cancer patient. World J Surg 33 : 1002-1009, 2009.
PubMed
11) Luu TD, et al : Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Ann Thorac Surg 85 : 1217-1223, 2008.
PubMed
12) Kato K, et al : Phase II Study of Chemoradiotherapy with 5-Fluorouracil and Cisplatin for Stage II-III Esophageal Squamous Cell Carcinoma : JCOG Trial (JCOG 9906). Int J Radiat Oncol Biol Phys, 2010. [Epub ahead of print]
 
13) Stahl M, et al : Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23 : 2310-2317, 2005.
PubMed
P.226 掲載の参考文献
1) 日本食道学会 (編) : 食道癌取扱い規約 (第10版), p56-59, 金原出版, 2007.
 
2) 日本胃癌学会 (編) : 胃癌取扱い規約 (第14版), p5-6, 金原出版, 2010.
 
3) Siewert JR, Stein HJ : Adenocarcinoma of the gastroesophageal junction : classification, pathology and extent of resection. Dis Esophagus 9 : 173-182, 1996.
 
4) 梶山美明, 鶴丸昌彦 : 食道癌・胃癌手術の標準的リンパ節郭清 : How to do it? 胸部上部食道癌. 手術 61 (3) : 265-270, 2007.
 
P.229 掲載の参考文献
1) 日本食道学会 (編) : 食道癌診断・治療ガイドライン2007年4月版, 金原出版, 2007.
 
2) 小山恒男ほか : 第46回食道色素研究会アンケート調査報告, 転移のあったm3sm1食道癌の特徴. 胃と腸 37 : 71-74, 2002.
 
3) Bollschweiler E, et al : High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 38 : 149-156, 2006.
PubMed
4) Oyama T, et al : Endoscopic submucosal dissection on early esophageal cancer. Clin Gastroenterol Hepatol 3 (7 Suppl 1) : S67-70, 2005.
 
5) Fujishiro M, et al : Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol 4 : 688-694, 2006.
PubMed
6) Ishihara R et al : Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 68 : 1066-1672, 2008.
PubMed
7) Takahashi H, et al : Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus. Gastrointest Endosc 72 : 255-264, 2010.
PubMed
8) 小山恒男 : 食道癌に対するESD. 外科治療 100 : 748-753, 2009.
Medical*Online
9) Shaheen NJ, et al : Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 360 : 2277-2288, 2009.
PubMed
10) 小山恒男ほか : 食道扁平上皮癌に対するESDの成績MM, SM1を中心に. 胃と腸 44 : 405-416, 2009.
 
11) Oyama T, Kitamura Y : The prevention of stricture after circumferential esophageal endoscopic submucosal dissection-Can steroid injection reduce the number of balloon dilatation? Gastrointest Endosc 69 : AB359, 2009.
 
12) 竹内学ほか : 食道表在癌内視鏡的相対適応病変に対するESDの有用性と問題点. Gastroenterol Endosc 50 : 2302, 2010.
 
13) 山口直之ほか : 食道ESD後狭窄に対するステロイド経口投与の有用性. 日消誌 107 : A767, 2010.
 
P.235 掲載の参考文献
1) Makuuchi H : Endoscopic mucosal resection for early esophageal cancer-indication and techniques. Dig Endosc 8 : 175-179, 1996.
 
2) 日本食道学会 (編) : 食道癌診断・治療ガイドライン, 金原出版, 2007.
 
3) 幕内博康ほか : m3・sm1食道癌に対するEMRの可能性. 胃と腸 33 : 993-1002, 1998.
 
4) Shimada H, et al : Technique of the double-channel ESD method performed with an EEMR-tube. Esophagus 8 : 67-70, 2011.
 
5) 島田英雄ほか : 従来法による食道EMRのメリットと適応および治療成績. 消化器内視鏡 20 : 291-297, 2008.
Medical*Online
6) Makuuchi H, et al : Four-step endoscopic esophageal mucosal resection (EEMR) tube method of resection for early esophageal cancer. Endoscopy 36 : 1013-1018, 2004.
PubMed
P.242 掲載の参考文献
1) 門馬久美子ほか : 食道粘膜癌の内視鏡的治療-内視鏡的粘膜切除 (mucosectomy) を中心に. 消化器 2 : 501-506, 1990.
 
2) 門馬久美子ほか : 食道扁平上皮癌に対するEMRとESDの使い分け. 胃と腸 44 : 325-334, 2009.
 
3) 門馬久美子ほか : 早期食道癌に対する内視鏡治療食道2チャンネル法. 胃と腸 41 : 466-473, 2006.
 
4) 門馬久美子ほか : 食道粘膜切除における改良型把持鉗子の有用性. 消化器内視鏡の進歩 39 : 120-123, 1991.
 
P.246 掲載の参考文献
1) Inoue H, Endo M : Endoscopic esophageal mucosal resection using a transparent tube. Surg Endosc 4 (4) : 198-201, 1990.
PubMed
2) Inoue H, et al : Endoscopic resection of carcinoma in situ of the esophagus accompanied by esophageal varices. Surg Endosc 5 (4) : 182-184, 1991.
PubMed
3) Inoue H, et al : Endoscopic resection of early-stage esophageal cancer. Surg Endosc 5 (2) : 59-62, 1991.
PubMed
4) Inoue H, et al : Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 39 (1) : 58-62, 1993.
PubMed
P.253 掲載の参考文献
1) 常岡健二, 内田隆也 : われわれの考案した内視鏡下の胃ポリープ切断採取法. Gastroenterol Endosc 11 : 174-184, 1969.
 
2) 小山恒男 : 食道癌に対するEMRの選択法. 消化器内視鏡 12 : 718-719, 2000.
 
3) Oyama T, Kikuchi Y : Aggressive endoscopic mucosal resection in the upper GI tract-Hook knife EMR method. Min Invas Ther & Allied Technol 11 : 291-295, 2002.
 
4) 小野裕之ほか : ITナイフを用いたEMR-適応拡大の工夫. 消化器内視鏡 11 : 675-681, 1999.
 
5) Oyama T, et al : Endoscopic submucosal dissection on early esophageal cancer. Clin Gastroenterol Hepatol 3 (7 Suppl 1) : S67-70, 2005.
 
6) Ishihara R, et al : Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 68 : 1066-1072, 2008.
PubMed
7) Takahashi H, et al : Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus. Gastrointest Endosc 72 : 255-264, 2010.
PubMed
8) 小山恒男 : 食道の切開・剥離EMR. Endoscopic surgery切開・剥離EMR-Hookナイフを中心に, p55-63, 日本メディカルセンター, 2003.
 
9) 平澤大ほか : フックナイフを用いたESD. 臨牀消化器内科 19 : 1205-1210, 2004.
 
10) 小山恒男ほか : 早期癌に対する内視鏡治療 ; 食道ESD. 胃と腸 41 : 491-497, 2006.
 
11) 平澤大ほか : ここまでできる食道ESD. 消化器内視鏡 18 : 179-185, 2006.
 
12) 福島豊美, 小山恒男 : ESDの工夫 : 上部消化管. Annual Review消化器, 中外医学社, p 54-60, 2011.
 
13) 小山恒男ほか : Hooking knife法with intro-gastric lesion lifting method. 胃と腸 37 : 1155-1161, 2002.
 
14) 小山恒男 : 食道ESDのコツ-糸付きクリップによるカウンタートラクション. 消化器内視鏡 23 : 130-133, 2011.
Medical*Online
15) Hirasawa D, et al : Handmade outer flushing channel for safe endoscopic mucosal resection. Digest Endosc 17 : 183-185, 2005.
 
P.260 掲載の参考文献
1) 多田正弘ほか : Strip-off biopsyの開発. Gastroenterol Endosc 26 : 833-839, 1984.
 
2) 平尾雅紀ほか : 胃の腫瘍性病変に対する内視鏡的切除法. Gastroenterol Endosc 25 : 1942-1953, 1983.
 
3) 竹腰隆男ほか : 内視鏡的ポリペクトミーによる早期胃癌の治療-curative polypectomyの有用性について. 癌の臨床 32 : 1185-1190, 1986.
 
4) 幕内博康ほか : 食道表在癌に対するEndoscopic surgery. 手術 46 : 603-609, 1993.
 
5) 井上晴洋ほか : 早期胃癌に対する内視鏡的粘膜切除術-透明プラスチックキャップを用いる方法 (EMRC)-. Gastroenterol Endosc 35 : 600-607, 1993.
 
6) 小野裕之ほか : ITナイフを用いたEMR-適応拡大の工夫-. 消化器内視鏡 11 : 675-678, 1999.
 
7) Gotoda T, et al : Incidence of lymph node metastasis from early gastric cancer. The estimation using a large number of cases in two large centers. Gastric Cancer 3 : 219-225, 2000.
PubMed
8) 小山恒男ほか : 食道癌に対するEMRの選択方法 ; 新しいEMR手技 Hooking EMR methodの有用性. 臨床消化器内科 16 : 1609-1615, 2001.
 
9) 矢作直久ほか : 早期胃癌に対する細径スネアを用いたEMRのコツ. 消化器内視鏡 11 : 1741-1746, 2003.
 
10) 山本博憲 : ビアルロン酸ナトリウムを用いた内視鏡的粘膜切除術. 臨床消化器内科 16 (3) : 375-380, 2001.
 
11) 井上晴洋ほか : 切開・剥離法の工夫-わたしはこうしている : 三角ナイフを用いた切開・剥離法. 胃と腸 39 : 73 -75, 2004.
 
12) Inoue H, et al : Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 42 : 265-271, 2010.
PubMed
13) 日本食道疾患研究会 (編) : 食道癌治療ガイドライン, p3-6, 金原出版, 2002.
 
14) Satodate H, et al : Circumferential EMR of carcinoma arising in Barretでsesophagus : case report. Endoscopy 58 : 288-292, 2003.
 
15) 井上晴洋ほか : 食道全周性ESDと予防的拡張術. 胃と腸 44 : 394-397, 2009.
 
16) 山口直之ほか : 食道ESD後狭窄に対するステロイド経口投与の有用性. 日消誌 107 : A767, 2010.
 
P.268 掲載の参考文献
1) 坂本菊男ほか : 下咽頭癌T1, T2症例の治療成績-再発症例の検討-. 日気食会報 56 : 265-272,
 
2) 千々和秀記ほか : 下咽頭癌T3・T4症例の治療成績. 日気食会報 56 : 458-464, 2005.
 
3) 藤田博正 : パネルディスカッション1「頸部食道癌の外科的治療」司会者のまとめ. 日気食会報 109-110, 2006.
 
4) 藤田博正, 甲能直幸 : シンポジウム3「進行咽頭・頸部食道癌に対する治療戦略」司会者のまとめ. (in press)
 
5) 梅野博仁ほか : 下咽頭癌・頸部食道癌の放射線療法後に対するSalvage Surgeryの検討. 日気食会報 115-121, 2010.
 
6) 千々和秀記ほか : 下咽頭・食道同時性重複癌症例の臨床的検討-喉頭, 食道温存を目指して-. 日気食会報 56 : 343-348, 2005.
 
7) 日本食道学会 (編) : 食道癌取扱い規約, 第10版補訂版, 金原出版, 2008.
 
8) Fujita H, et al : A new N category for cancer of the cervical esophagus based on lymph node compartment Esophagus 5 : 19-26, 2008.
 
9) 千々和圭一ほか : 下咽頭・頸部食道癌のリンパ節郭清術. 手術 56 : 1581-1587, 2002.
 
10) 藤田博正ほか : 遊離空腸を用いた咽・喉頭再建術. 消化器外科 24 : 189-196, 2001.
 
11) 藤田博正ほか : 食道切除後の再建術-遊離空腸間置術. 消化器外科 25 : 19-26, 2002.
 
12) 藤田博正ほか : 頸部食道癌の標準的リンパ節郭清術. 手術 61 : 259-264, 2007.
 
13) 藤田博正, 森直樹 : 頸部食道癌手術. 手術 60 : 699-706, 2006.
 
P.273 掲載の参考文献
1) 川村康之 : 食道のリンパ管の微細分布. 東京医大誌 33 : 103-113, 1975.
 
2) 鶴丸昌彦ほか : 気管・気管支周囲のリンパ節郭清. 手術 58 : 1-6, 2004.
 
3) Tsurumaru M, et al : Three-field esophagectomy. In : Adult Chest Surgery (ed by Sugarbaker D, et al), p171-182, McGraw Hill, New York, 2009.
 
P.277 掲載の参考文献
1) 日本食道学会 (編) : 食道癌取扱い規約, 第10版, 金原出版, 2007.
 
2) 鍋谷欣一, 本島悌司 : 胸部食道癌手術の再建法の検討. 消化器外科 3 : 645-651, 1980.
 
3) 日本食道疾患研究会全国登録委員会 (編) : 全国食道がん登録調査報告, 協進社, 1998.
 
4) Yamato T, et al : Esophagoplasty with an autogenous tubed gastric flap. Am J Surg 137 : 597-602, 1979.
PubMed
5) El-Eishi HI, et al : The arterial supply of the human stomach. Acta Anat 86 : 565-580, 1973.
PubMed
6) 佐藤達夫 : 消化器の局所解剖学 食道・胃, p257-263, 金原出版, 1993.
 
7) 加藤抱一ほか : 食道癌のリンパ節転移と治療成績. 日消外会誌 22 : 1729-1737, 1989.
 
8) 鶴丸昌彦ほか : 胃による食道再建術. 手術 46 : 361-368, 1992.
 
9) 細川正夫ほか : 左右反回神経確認と周囲リンパ節郭清. 消化器外科 30 : 141-148, 2007.
 
10) 細川正夫ほか : 胸部食道癌根治手術 開胸・開腹手術. 手術 63 : 707-712, 2009.
 
11) 内山八郎, 加治佐隆 : 食道癌手術における縫合不全. 臨床外科 20 : 587-591, 1965.
 
12) Collard JM, et al : Terminalized semimechanical side-to-side suture technique for cervical esophagogastrostomy. Ann Thorac Surg 65 : 814-817, 1998.
PubMed
P.283 掲載の参考文献
1) 河野辰幸ほか : 食道癌切除後再建術. 手術 60 : 739-746, 2006.
 
2) 毛受松寿ほか : 胸部食道癌に対する空腸による食道再建術. 手術 34 : 1109-1117, 1980.
 
3) 西蔭徹郎, 河野辰幸 : 結腸による食道再建・バイパス術. 消化器外科手術ナビガイド (笹子三津留ほか編), p165-175, 中山書店, 2010.
 
4) Popovici Z : A new philosophy in esophageal reconstruction with colon. Dis Esophagus 16 : 323-327, 2003.
PubMed
5) Kawano T, et al : Subcutaneous reconstruction using ileo-colon with preserved ileo-colic vessels following esophagectomy or in esophageal bypass operation. Dig Surg 26 : 200-204, 2009.
PubMed
6) 西蔭徹郎ほか : 回結腸による食道再建術を安定して行うための工夫. 手術 60 : 193-197, 2006.
 
7) 西蔭徹郎, 河野辰幸 : 食道再建術再建のみ (小腸再建). Digestive Surgery NOW No.6, 食道・胃外科手術, 標準手術からのステップアップ (上西紀夫編), p50-66, メジカルビュー, 2009.
 
8) 石川雅章 : 胸部食道全摘後の再建 ; 有茎空腸を頸部まで挙上する工夫. 消化器外科 29 : 1355-1358, 2006.
 
9) 細谷好則 : 食道再建術 (小腸再建法) 血管吻合付加 (スーパーチャージ) を伴うRoux-en-Y型空腸再建. 手術 58 (6) : 807-811, 2004.
 
P.293 掲載の参考文献
1) Cuschieri A : Endoscopic subtotal oesophagectomy for cancer using the right thoracoscopic approach. Surg Oncol 2 (SupPl 1) : 3-11, 1993.
 
2) Akaishi T, et al : Thoracoscopic en bloc total esophagectomy with radical mediastinal lymphadenectomy. J Thorac Cardiovasc Surg 112 : 1533-1540, 1996.
PubMed
3) Osugi H, et al : Learning curve of video-assisted thoracoscopic esophagectomy and extended lymphadenectomy for squamous cell cancer of the thoracic esophagus and results. Surg Endosc 17 : 515-519, 2003.
 
4) Taguchi S, et al : Comparison of three-field esophagectomy for esophageal cancer incorporating open or thoracoscopic thoracotomy. Surg Endosc 17 : 1445-1450, 2003.
PubMed
5) Iwasaki H, et al : Advantages of pulmonary function after thoracoscopic esophagectomy over open surgery. Osaka City Med J 54 : 53-61, 2008.
 
P.297 掲載の参考文献
1) Cuschieri A et al : Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 37 (1) : 7-11, 1992.
PubMed
2) Noshiro H, et al : Minimally invasive radical esophagectomy for esophageal cancer. Esophagus 4 : 59-65, 2007.
 
3) 能城浩和ほか : 胸部食道癌に対する鏡視下食道切除・再建術. 手術 58 (3) : 369-374, 2004.
 
4) Palanivelu C, et al : Minimally invasive esophagectomy : thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position-experience of 130 patients. J Am Coll Surg 203 (1) : 7-16, 2006.
PubMed
5) Fabian T, et al : Thoracoscopic esophageal mobilization during minimally invasive esophagectomy : a head-to-head comparison of prone versus decubitus positions. Surg Endosc 22 (11) : 2485-2491, 2008.
PubMed
6) Noshiro H, et al : Lymphadenectomy along the left recurrent laryngeal nerve by minimally invasive esophagectomy in the prone position for thoracic esophageal cancer. Surg Endosc 24 (12) : 2965-2973, 2010.
PubMed
7) 能城浩和ほか : 胸部食道癌に対する腹臥位鏡視下食道切除術. 外科治療 100 : 474-482, 2009.
Medical*Online
8) 能城浩和ほか : 腹臥位鏡視下食道切除術. 手術 63 : 1909-1913, 2010.
 
9) 能城浩和ほか : 食道癌に対する腹臥位鏡視下食道切除術. 消化器外科 NOW No 10. 鏡視下食道癌手術と肥満の外科治療. p34-46, メジカルビュー社, 2010.
 
P.304 掲載の参考文献
1) Akiyama H, et al : Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 220 : 372-373, 1994.
 
2) 遠藤光夫 : 食道表在癌におけるリンパ節転移の状況と治療方針. 外科治療 80 : 590-594, 1999.
Medical*Online
3) 幕内博康 : 外科学の進歩と今後の展望, 食道外科. 外科 69 : 402-407, 2007.
 
4) 河原英之ほか : 食道癌に対する胸腔鏡下食道亜全摘術. 手術 48 : 790-794, 1994.
 
5) 赤石隆ほか : 胸部食道癌手術・胸腔鏡下食道切除術ならびにリンパ節郭清法. 臨床外科 50 : 1401-1404, 1995.
 
6) 井上晴洋ほか : 胸部食道癌に対する鏡視下食道切除・再建術. 手術 52 : 879-884, 1998.
 
7) 大杉治司ほか : 拡大リンパ節郭清例におけるリンパ節転移状況と予後. 日本臨牀 61 (増刊号8) : 391-394, 2003.
Medical*Online
8) Cushieri A, et al : Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 37 : 7-11, 1992.
 
9) Palanivelu C, et al : Minimally invasive esophagectomy : thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position-experience of 130 patients. J Am Coll Surg 203 : 7-16, 2006.
PubMed
10) 宇山一朗ほか : 鏡視下食道癌手術. 日臨外会誌 68 : 334, 2007.
 
11) 井上晴洋ほか : 食道癌内視鏡外科手術-下縦隔郭清手技-. 手術 63 : 1903-1907, 2009.
 
P.309 掲載の参考文献
1) 礒垣淳ほか : 左半腹臥位による胸腔鏡下食道切除術. 臨床外科 65 : 620-627, 2010.
 
2) 石田善敬ほか : 図説 : 内視鏡手術支援ロボット. 日本臨牀 68 : 1212-1214, 2010.
 
3) Peracchia A, et al : Use of mini-invasive procedures in esophageal surgery. Chirurgie 118 : 305-308, 1992,
PubMed
4) Smithers BM, et al : Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg 245 : 232-240, 2007.
PubMed
5) Verhage RJ, et al : Minimally invasive surgery compared to open procedures in esophagectomy for cancer : a systematic review of the literature. Minerva Chir 64 : 135-146, 2009.
 
6) Zingg U, et al : Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann Thorac Surg 87 : 911-919, 2009.
PubMed
7) Cuschieri A : Thoracoscopic subtotal oesophagectomy. Endosc Surg Allied Technol 2 : 21-25, 1994.
PubMed
8) Palanivelu C, et al : Minimally invasive esophagectomy : thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position-experience of 130 patients. J Am Coll Surg 203 : 7-16, 2006.
PubMed
9) 能城浩和ほか : 胸部食道癌に対する腹臥位鏡視下食道切除術. 外科治療 100 : 474-481, 2009.
Medical*Online
10) van Hillegersberg R, et al : First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc 20 : 1435-1439, 2006.
PubMed
11) Kernstine KH, et al : The first series of completely robotic esophagectomies with three-field lymphadenectomy ; initial experience. Surg Endosc 21 : 2285 -2292, 2007.
 
12) Kim DJ, et al : Thoracoscopic esophagectomy for esophageal cancer ; Feasibility and safety of robotic assistance in the prone position. J Thorac Cardiovasc Surg 139 : 53-59, 2010.
PubMed
P.314 掲載の参考文献
1) 日本食道学会 : 食道癌取扱い規約第10版, p29-30, 金原出版2007.
 
2) Ueda Y, et al : Thoracic and cardiovascular surgery in Japan during 2006 : annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 56 : 365-388, 2008.
PubMed
3) Sasako M, et al : Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia : a randomised controlled trial. Lancet Oncol 7 : 644-651, 2006.
PubMed
4) 夏越祥次ほか : 食道浸潤胃癌に対する手術術式の選択と手技 進展状況に関する術前診断と手術術式の選択 とくに超音波検査所見を中心に. 消化器外科 15 : 1577-1586, 1992.
 
5) 奥村浩ほか : 胃による食道再建術 後縦隔胃挙上再建. 手術 63 : 423-426, 2009.
 
6) 前村公成ほか : 手術手技 新型深部持針器 (前村式日腸持針器) を用いた胆管空腸吻合術. 手術 64 : 521-525, 2010.
 
7) 有留邦明ほか : 胃全摘術後のY脚部空腸パウチRoux-Y法再建術.手術 58 : 1149-1152, 2004.
 
8) 奥村浩ほか : 下部食道噴門部癌手術 (左開胸法). 手術 60 : 805-809, 2006.
 
9) 夏越祥次ほか : 下部食道, 食道胃接合部癌手術 ; 回復を先行した左開胸法. 消化器外科 33 : 1913-1924, 2010.
 
10) 内門泰斗ほか : 消化器癌の診断・治療 食道癌 胸部食道癌 治療の実際. 消化器外科 32 : 699-705, 2009.
 
11) 内門泰斗ほか : 再建胃管血流不良. 手術 64 : 955-958, 2010.
 
P.321 掲載の参考文献
1) Linden PA, Sugarbaker DJ : Esophagectomy via right thoracotomy. In : Person's Thoracic and Esophageal Surgery, 3rd ed (ed by Patterson GA, et al), p 590-596, Churchill Livingstone Elsevier, Philadelphia, 2008.
 
2) Dubecz A, et al : The origins of an operation : a brief history of transhiatal esophagectomy. Ann Surg 249 : 535-540, 2009.
PubMed
3) Akiyama H, et al : Total esophageal reconstruction after extraction of the esophagus. Ann Surg 182 : 547-552, 1975.
PubMed
4) Orringer MB, Sloan H : Esophagectomy without thoracotomy. J Thorac Cardiovasc Surg 76 : 643-654, 1978.
PubMed
5) Orringer MB : Transhiatal esophagectomy. In : Person's Thoracic and Esophageal Surgery, 3rd ed (ed by Patterson GA, et al), p563-583, Churchill Livingstone Elsevier, Philadelphia, 2008.
 
6) Bumm R, et al : Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma. World J Surg 21 : 822-831, 1997.
PubMed
7) Sadanaga N, et al : Laparoscopy-assisted surgery : a new technique for transhiatal esophagectomy. Am J Surg 168 : 355-357, 1994.
PubMed
8) DePaula AL, et al : Laparoscopic transhiatal esophagectomy with esophagogastroplasty. Surg Laparosc Endosc 5 : 1-5, 1995.
PubMed
9) Avital S, et al : Laparoscopic transhiatal esophagectomy for esophageal cancer. Am J Surg 190 : 69-74, 2005.
PubMed
10) Van den Broek WT, et al : Laparoscopically assisted transhiatal resection for malignancies of the distal esophagus. Surg Endosc 18 : 812-817, 2004.
PubMed
11) Bernabe KQ, et al : Laparoscopic hand-assisted versus open transhiatal esophagectomy : a case control study. Surg Endosc 19 : 334-337, 2005.
 
12) Tangoku A, et al : Lymph node metastases identified with mediastinoscopy in patient with superficial carcinoma of the esophagus. Surg Endosc 14 : 595, 2000.
PubMed
13) Tangoku A, et al : Mediastinoscope-assisted transhiatal esophagectomy for esophageal cancer. Surg Endosc 18 : 383-389, 2004.
PubMed
14) 丹黒章ほか : ここまできた食道疾患の内視鏡下治療外科手術 食道癌に対する縦隔鏡下食道切除術外科治療 100 : 790-795, 2009.
 
15) 徳光幸生ほか : 肺癌根治術後の胸部中部食道癌に対して縦隔鏡下食道切除術を施行した1例. 癌と化学療法 36 : 2445-2447, 2009.
 
P.327 掲載の参考文献
1) 日本胃癌学会 (編) : 胃癌取扱い規約, 第14版, 金原出版, 2010.
 
2) International Union Against Cancer : TNM Classification of Malignant Tumours, 7th ed (ed by Sobin LH, et al), Wiley-Blackwell, New York, 2009.
 
3) 日本食道学会 (編) : 臨床・病理 食道癌取扱い規約, 第10版, 金原出版, 2007.
 
4) 西満正ほか : 噴門部癌について-食道胃境界部の提唱-. 外科治療 15 : 1328-1338, 1973.
 
5) Sasako M, et al : Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of cardia or subcardia : a randomised controlled study. Lancet Oncol 7 : 644-651, 2006.
PubMed
6) Siewert JR, Stein HJ : Adenocarcinoma of the gastroesophageal junction. Classification, pathology and extent of resection. Dis Esophagus 9 : 173-182, 1996,
 
7) Siewert JR, et al : Histologic tumor type is an independent prognostic parameter in esophageal cancer : lessons from more than 1,000 consecutive resection at a single center in Western world. Ann Surg 234 : 360-367, 2001.
 
8) Hulscher JB, et al : Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of esophagus. N Engl J Med 247 : 1662-1669, 2002.
 
9) 白川靖博ほか : Barrett食道表在癌切除症例の検討. 消化器科 41 : 42-49, 2005.
 
10) 竹内学ほか : Barrett食道表在癌の内視鏡診断および内視鏡治療. 消化器内視鏡 19 : 1468-1476, 2007.
Medical*Online
11) 日本食道学会 (編) : 食道癌診断・治療ガイドライン, 金原出版, 2007.
 
12) 食道疾患研究会 (編) : 第54回日本食道疾患研究会アンケート集計報告・下部食道胃接合部浸潤癌切除例, 2000.
 
13) 幕内博康 : [食道胃接合部に関する今日の話題提供] 外科医からみた食道胃接合部. 消化器内視鏡 19 : 1419-1427, 2007.
 
14) 猶本良夫ほか : 初回治療例 バレット食道表在癌 ; 迷走神経温存有茎空腸間置術. 消化器外科 28 : 1771-1779, 2005.
 
15) 千野修ほか : 胸部下部食道癌に対する右開胸開腹連続切開・下部食道噴門切除術. 手術 51 : 557-560, 1997.
 
P.334 掲載の参考文献
1) Kitagawa Y, et al : The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 80 : 1799-1809, 2000.
PubMed
2) Takeuchi H, Kitagawa Y : Sentinel node navigation surgery for esophageal cancer. Gen Thorac Cardiovasc Surg 56 : 393-396, 2008.
PubMed
3) Takeuchi H, et al : Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg 249 : 757-763, 2009.
PubMed
4) Grotenhuis BA, et al : The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 138 : 608-612, 2009.
PubMed
5) Kitagawa Y, et al : Sentinel lymph node mapping in esophageal and gastric cancer. Cancer Treat Res 127 : 123-139, 2005.
PubMed
6) Pring C, Dexter S : A laparoscopic vagus preserving Merendino procedure for early esophageal adenocarcinoma. Surg Endosc 24 : 1195-1199, 2010.
PubMed
7) Hulscher JB, et al : Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 : 1662-1669, 2002.
PubMed
8) Omloo JM, et al : Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus. Five-year survival of a randomized clinical trial. Ann Surg 246 : 992-1001, 2007.
PubMed
9) Kato H, et al : Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer 98 : 932-939, 2003.
PubMed
10) Yasuda S, et al : Sentinel lymph node detection with Tc-99m tin colloids in patients with esophagogastric cancer. Jpn J Clin Oncol 33 : 68-72, 2003.
PubMed
11) Lamb PJ, et al : Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg 92 : 60-67, 2005.
PubMed
12) Arima H, et a1 : Area of nodal metastasis and radioisotope uptake in sentinel nodes of upper gastrointestinal cancer. J Surg Res 135 : 250-254, 2006.
 
13) Thompson SK, et al : Feasibility study of sentinel lymph node biopsy in esophagcal cancer with conservative lymphadenectomy. Surg Endosc 25 : 817-825, 2011.
 
P.340 掲載の参考文献
1) 日本食道学会 (編) : 食道癌診断・治療ガイドライン2007年4月版, 第2版, 金原出版, 2007.
 
2) Ando N, et al : Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232 : 225-232, 2000.
PubMed
3) Ando N, et al : Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus : a Japan Clinical Oncology Group Study-JCOG9204, J Clin Oncol 21 : 4592-4596, 2003.
 
4) Igaki H, et al : A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). J Clin Oncol 26 (Suppl) : abstr 4510, 2008.
 
5) Law S, et al : Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus : a prospective randomized trial. J Thorac Cardiovasc Surg 144 : 210-217, 1997.
 
6) Kelsen DP, et al : Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 : 1979-1984, 1998.
PubMed
7) Medical Research Council Oesophageal Cancer Working Party : Surgical resection with or without preoperative chemotherapy in oesophageal cancer : a randomized controlled trial. Lancet 359 : 1727-1733, 2002.
PubMed
8) Walsh TN, et al : A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 : 462-467, 1996.
PubMed
9) Bosset JF, et al : Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 : 161-168, 1997.
PubMed
10) Urba S, et al : Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 : 305-313, 2001.
 
11) Burmeister BH, et al : Surgery alone versus chemoradiotherapy followed by surgery for respectable cancer of the oesophagus : a randomized controlled phase III trial. Lancet Oncol 6 : 659-668, 2005.
PubMed
12) Tepper J, et al : Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer : CALGB 9781. J Clin Oncol 26 : 1086-1092, 2008.
PubMed
13) Gebski V, et al : Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma : a meta-analysis. Lancet Oncol 8 : 226-234, 2007.
 
14) Van Cutsem E, et al : Phase III study of docetaxel and cisplatin plus fluorouracil compared with cis platin and fluorouracil as first-1ine therapy for advanced gastric cancer : a report of the V325 Study Group. J Clin Oncol 24 : 4991-4997, 2006.
 
15) Posner MR, et al : Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 : 1705-1715, 2007.
 
P.347 掲載の参考文献
1) Hayashi K, et al : Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus : a Japan Esophageal Oncology Group (JEOG) Trial (JCOG 9407). Jpn J Clin Oncol 31 : 419-423, 2001.
 
2) Muro K, et al : A phase II study of nedaplatin and 5-fluorouracil in metastatic squamous cell carcinoma of the esophagus : The Japan Clinical Oncology Group (JCOG) Trial (JCOG 9905). Proc Am Soc Clin Oncol 22 : 1112, 2003.
 
3) Mauer AM, et al : Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol 16 : 1320-1325, 2005.
PubMed
4) Cunningham D, et al : Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358 : 36-46, 2008.
PubMed
5) Ajani JA, et al : Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86 : 1086-1091, 1994.
PubMed
6) Metges JP, et al : Docetaxel (DOC) as a second line chemotherapy in metastatic esophageal cancer (MEC) : a French Study. Proc Am Soc Clin Oncol 20 : 160a, 2001.
 
7) Heath EI, et al : Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus. Invest New Drugs 20 : 95-99, 2002.
PubMed
8) Muro K, et al : A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 15 : 955-959, 2004.
 
9) Kato K, et al : A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy. Cancer Chemother Pharmacol 67 : 1265-1272, 2011.
PubMed
10) Van Cutsem E, et al : Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer : a report of the V325 Study Group. J Clin Oncol 24 : 4991-4997, 2006.
 
11) Vermorken JB, et al : Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 : 1695-1704, 2007.
PubMed
12) Posner MR, et al : Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 : 1705-1715, 2007.
 
13) Bonner JA, et al : Radiotherapy plus Cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 : 567-578, 2006.
PubMed
14) Lorenzen S, et al : Cetuximab plus cisplatin-5-fiuorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus : a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 20 : 1667-1673, 2009.
 
15) Bang YJ, et al : Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA) : a phase 3, open-label, randomised controlled trial. Lancet 376 : 687-697, 2010.
 
P.353 掲載の参考文献
1) Withers HR, et al : Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 31 : 353-359, 1995.
PubMed
2) Okawa T, et al : Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Int J Radiat Oncol Biol Phys 45 : 623-628, 1999.
 
3) 根本建二, 山田章吾 : 6. 消化器 1. 食道癌. 放射線治療計画ガイドライン・2008 (日本放射線科専門医会・医会, 日本放射線腫瘍学会, 日本医学放射線学会編), p157-163, 2008.
 
4) 池田道雄ほか : 食道癌の放射線治療基準. 癌の臨床 33 : 1001-1019, 1987.
 
5) 西尾正道ほか : 食道癌の照射線量-外照射単独ならびに腔内照射併用-. 日放腫会誌 10 : 49-54, 1998.
 
6) 大川智彦ほか : [食道癌・放射線照射の最適化] に関する臨床研究 (最終報告). 日放腫会誌 11 (1) : 53-58, 1999.
 
7) 日本食道疾患研究会事務局 (編) : 日本食道疾患研究会委員会活動報告集 (1998年), p36-53, 1999.
 
8) 西尾正道 : 放射線治療の最前線 消化器病セミナー99 食道癌治療の最前線 (幕内博康編), p129-145, へるす出版, 2005.
 
9) 西尾正道ほか : 食道癌M0症例の放射線治療成績の全国集計. J Jpn Soc Cancer Ther 27 (5) : 912-924, 1992.
 
10) 西尾正道ほか : 癌の放射線治療と形態保存-食道癌-. 臨床放射線 35 : 1483-1489, 1990.
 
11) 西尾正道 : 放射線療法. 消化器病セミナー 69 食道癌-診断と治療の進歩- (杉町圭蔵編), p143-154, へるす出版, 1997.
 
12) Non-small Cell Lung Cancer Collaborative Group : Chemotherapy in non-small cell lung cancer : a meta-analysis using update data on individual patients from 52 randomized clinical trials. BMJ 311 : 899-909, 1995.
 
13) Pignon JP, et al : Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma : three meta-analyses of updated individual data. Lancet 355 : 949-955, 2000.
PubMed
P.357 掲載の参考文献
1) Honda M, et al : Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma. Dis Esophagus 23 : 641-645, 2010.
PubMed
2) Urba SG, Turrisi AT 3rd : Split-course accelerated radiation therapy combined with carboplatin and 5-fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus. Cancer 75 : 435-439, 1995.
PubMed
3) Kassam Z, et al : A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus. Clin Oncol 20 : 53-60, 2008.
 
4) Hayter CR, et al : A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer. Radiother Oncol 56 : 329-333, 2000.
PubMed
5) Javed A, et al : Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma : a randomized trial. J Gastrointest Cancer (journal online) [http://www.springerlink.com/content/2k2t048627823271/fulltext.pdf], 2010.
PubMed
6) Nishimura Y, et al : Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents : a questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys 56 : 1327-1332, 2003.
 
7) Nemoto K, et al : Radiation therapy for loco-regionally recurrent esophageal cancer after surgery. Radiother Oncol 61 : 165-168, 2001.
PubMed
8) Jingu K et al : Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer 6 : 50 (journal online), 2006.
 
9) 根本建二ほか : 食道癌再照射例の検討. 日放腫会誌 3 : 71-76, 1991.
 
10) Weinberg JS, et al : Metastasis of esophageal carcinoma to the brain. Cancer 98 : 1925-1933, 2003.
 
11) Muller-Riemenschneider F, et al : Stereotactic radiosurgery for the treatment of brain metastases. Radiother Oncol 91 : 67-74, 2009.
PubMed
12) Ogawa K, et al : Brain metastases from esophageal carcinoma : natural history, prognostic factors, and outcome. Cancer 94 : 759-764, 2002.
PubMed
13) Wu JS, et al ; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group : Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 55 : 594-605, 2003.
PubMed
14) Finlay IG, et al : Radioisotopes for the palliation of metastatic bone cancer : a systematic review. Lancet Oncol 6 : 392-400, 2005.
PubMed
P.362 掲載の参考文献
1) 阿久津泰典ほか : 食道癌におけるトランスレーショナルリサーチの新展開. 消化器外科 31 (11) : 1663-1672, 2008.
 
2) 安田茂雄ほか : 食道癌に対する粒子線治療 日本医事新報 4496 : 49-53, 2010.
Medical*Online
3) 辻井博彦, 浅香正博 : 消化器癌に対する放射線治療の進歩. Frontiers in Gastroenterology 12 (3) : 181-187, 2007.
Medical*Online
4) 放射線医学総合研究所重粒子医科学センター : 重粒子線がん治療臨床試験報告書 (2), 2005.
 
5) 松原久裕 : 食道癌の術前治療. 日外科系連会誌 34 (1) : 121-122, 2009.
 
P.367 掲載の参考文献
1) Herskovic A, et al : Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (24) : 1593-1598, 1992.
PubMed
2) al-Sarraf M, et al : Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer : an intergroup study. J Clin Oncol 15 (1) : 277-284, 1997.
PubMed
3) Cooper JS, et al : Chemoradiotherapy of locally advanced esophageal cancer : long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281 (17) : 1623-1627, 1999.
PubMed
4) Minsky BD, et al : INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer : high-dose versus standard-dose radiation therapy. J Clin Oncol 20 (5) : 1167-1174, 2002.
PubMed
5) Kato H, et al : A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma : Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 39 (10) : 638-643, 2009.
 
6) Kato K et al : Phase II Study of Chemoradiotherapy with 5-Fluorouracil and Cisplatin for Stage II-III Esophageal Squamous Cell Carcinoma : JCOG Trial (JCOG 9906). Int J Radiat Oncol Biol Phys, 2010. [Epub ahead of print]
 
7) Nakajima TE, et al : A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer. Jpn J Clin Oncol 39 (1) : 37-42, 2009.
PubMed
8) 田中正博ほか : 食道癌に対する根治的化学放射線療法後の晩期合併症とその対策 晩期毒性の軽減を目的としたRTOGレジメン化学放射線療法の臨床第II相試験. 第63回日本食道学会学術集会プログラム・抄録集, p105, 2009.
 
9) 三梨桂子ほか : 食道がんに対する集学的治療の新展開 Stage II-III食道癌に対する集学的治療としての根治的化学放射線療法 (CRT) の治療成績. 日癌治療会誌 45 (2) : 319, 2010.
 
10) Ohtsu A, et al : Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17 (9) : 2915-2921, 1999.
 
11) Ishida K, et al : Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus : a Japan Esophageal Oncology Group (JEOG) / Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol 34 (10) : 615-619, 2004.
PubMed
12) Safran H, et al : Cetuximab with concurrent chemoradiation for esophagogastric cancer : assessment of toxicity. Int J Radiat Oncol Biol Phys 70 (2) : 391-395, 2008.
PubMed
P.372 掲載の参考文献
1) Ohtsu A, et al : Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17 : 2915-2921, 1999.
 
2) Ishida K, et al : Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus : a Japan Esophageal Oncology Group (JEOG) / Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol 34 : 615-619, 2004.
PubMed
3) Yano T, et al : Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 40 : 717-721, 2008.
PubMed
4) Nishimura M, et al : Salvage esophagectomy following definitive chemoradiotherapy. Gen Thorac Cardiovasc Surg 55 : 461-465, 2007.
PubMed
5) Ariga H, et al : Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75 : 348-356, 2009.
PubMed
6) Oki E, et al : Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer. Dis Esophagus 20 : 301-304, 2007.
PubMed
7) Miyata H, et al : Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol 100 : 442-446, 2009.
PubMed
8) Takeuchi H, et al : Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg 34 : 277-284, 2010.
 
9) Kato H, et al : Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography. Anticancer Res 27 : 2627-2633, 2007.
PubMed
10) Tomimaru Y, et al : Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol 93 : 422-428, 2006.
PubMed
11) Tachimori Y, et al : Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137 : 49-54, 2009.
PubMed
12) Fujita H, et al : Mediastinal lymphnode dissection procedure during esophageal cancer operation-carefully considered for preserving respiratory function. Jpn J Surg 18 : 31-34, 1988.
PubMed
13) Nakamura T, et al : Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 188 : 261-266, 2004,
PubMed
14) Swisher SG, et al : Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123 : 175-183, 2002.
PubMed
15) Ishikura S, et al : Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21 : 2697-2702, 2003.
PubMed
P.378 掲載の参考文献
1) Dolmans DE, et al : Photodynamic therapy for cancer. Nat Rev Cancer 3 : 380-387, 2003.
PubMed
2) Dolmans DE, et al : Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodymanic therapy. Cancer Res 62 : 2151-2156, 2002.
 
3) Korbelik M, et al : The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res 56 : 5647-5652, 1996.
PubMed
4) 中村哲也ほか : レーザー内視鏡治療ガイドライン. 消化器内視鏡ガイドライン, 第3版 (日本消化器内視鏡学会監), p299-309, 医学書院, 2006.
 
5) 吉田一成ほか : PHE (Porfimer Sodium) およびエキシマダイレーザー (PDT EDL-1) による食道表在癌に対するPhotodynamic therapy (PDT) の臨床第II相試験癌と化学療法 20 : 2063-2066, 1993.
 
6) Tanaka T, et al : Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus. Gastrointest Endosc 73 : 1-6, 2011.
PubMed
7) Savary JF, et al : Photodynamic therapy of early squamous cell carcinomas of the esophagus : a review of 31 cases. Endoscopy 30 (3) : 258-265, 1998.
PubMed
8) Lightdale CJ, et al : Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd : YAG laser for palliation of esophageal cancer : a multicenter randomized trial. Gastrointest Endosc 42 (6) : 507-512, 1995.
 
9) Litle VR, et al : Photodynamic therapy as palliation for esophageal cancer : experience in 215 patients. Ann Thorac Surg 76 (5) : 1687-1692, 2003.
PubMed
10) Overholt BF, et al : Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc 66 (3) : 460-468, 2007.
 
11) Pech O, et al : Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high grade intraepitherial neoplasia. Gastrointest Endosc 62 (1) : 24-30, 2005.
 
12) Yano T, et al : Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 62 (1) : 31-36, 2005.
PubMed
P.386 掲載の参考文献
1) 日本食道学会 (編) : 食道癌診断・治療ガイドライン, 金原出版, 2007.
 
2) 丹黒章ほか : 食道癌. 消化器外科 33 (6) : 1005-1014, 2010.
 
3) Yoshida T, et al : Preoperative chemotherapy with weekly docetaxel plus low dose cisplatin and 5-fluorouracil for stage II/III squamous cell carcinoma of the esophagus. Esophagus 7 : 95-100, 2010.
 
4) 清家純一ほか : Docetaxel/5-FU/CDDPおよびS-1/docetaxel療法による術前化学療法にて病理学的CRが得られた進行食道癌の1例. 癌と化学療法 35 (4) : 633-636, 2008.
 
5) 宗田真ほか : 食道癌による狭窄, 気管 (支) 瘻. 外科 71 (7) : 685-691, 2009.
 
6) Frenken M : Best palliation in esophageal cancer : surgery, stenting, radiation, or what? Dis Esophagus 14 : 120-123, 2001.
 
7) Litle VR, Christie NA : Palliation of esophageal cancer. In : Person's Thoracic and Esophageal Surgery, 3rd ed (ed by Patterson GA, et al), p527-531, Churchill Livingstone Elsevier, Philadelphia, 2008.
 
8) 西巻正ほか : 胸部食道癌の姑息的療法の実際. 外科治療 95 (3) : 272-282, 2006.
 
9) Mitani M, et al : The effectiveness of palliative resection for advanced esophageal carcinoma : Analysis of 24 consecutive cases. Surg Today 32 : 784-788, 2002.
PubMed
10) 棟方正樹 : II. 悪性食道気管瘻に対する治療 a) IVR (ステント) による治療が期待できる症例. 臨床腫瘍プラグティス 5 (1) : 60-63, 2009.
 
11) 嶋尾仁ほか : 消化管のブジー拡張・ステント挿入ガイドライン. 消化器内視鏡ガイドライン, 第2版 (日本消化器内視鏡学会監), p225-243, 医学書院, 2002.
 
12) Nishimura Y, et al : Severe complication in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents : questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys 56 : 1327-1332, 2003.
 
13) 岸和史ほか : 気道系のステント 第37回日本IVR学会総会「技術教育セミナー」. IVR : Interventional Radiology 24 : 171-177, 2009.
 
14) 梶山美明ほか : 切除不能胸部食道癌に対する胃挙上バイパス術. 手術 60 (9) : 1265-1270, 2006.
 
15) 木ノ下義宏ほか : 食道癌に対するステント療法と食道バイパス療法の比較. 外科治療 95 : 403-404, 2006.
Medical*Online
P.390 掲載の参考文献
1) Swisher SG, et al : Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 91 : 763-771, 1999.
PubMed
2) Shimada H, et al : Preclinical study of adenoviral p53 gene therapy for esophageal cancer. Surg Today 31 : 597-604, 2001.
PubMed
3) Shimada H, et al : Facilitation of adenoviral wild-type p53-induced apoptotic cell death by over expression of p33 (ING1) in TTn human esophageal carcinoma cells. Oncogene 21 : 1208-1216, 2002.
 
4) Ma G, et al : Cytotoxicity of adenoviruses expressing the wild-type p53 gene to esophageal carcinoma cells is linked with the CAR expression level and indirectly with the endogenous p53 status. Cancer Gene Ther 16 : 832-840, 2009.
PubMed
5) Shimada H, et al : Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma. Cancer Sci 97 : 554-601, 2006.
PubMed
6) Kawahira H, et al : Viral shedding after p53 adenoviral gene therapy in 10 cases of esophageal cancer. Cancer Sci 101 : 289-291, 2010.
PubMed
7) Yang ZX, et al : Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma. J Cancer Res Clin Oncol 136 : 625-630, 2010.
PubMed
8) Pan JJ, et al : Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol 27 : 799-804, 2009.
PubMed
9) Ma G, et al : Gene medicine for cancer treatment : Commercially available medicine and accumulated clinical data in China. Drug Des Devel Ther 2 : 115-122, 2009.
PubMed
10) Senzer N, et al : Long-term outcome in esophageal cancer after endoscopically delivered intratumoral (IT) injections of TNFerade with neoadjuvant chemoradiotherapy (CRT). 2006 Gastrointestinal Cancers Symposium Abstract No : 9, 2006.
 
11) Lu W, et al : Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers : A pilot phase II clinical trial. World J Gastroenterol 10 : 3634-3638, 2004.
PubMed
12) Nemunaitis J, et al : A phase I study of telomerase specific replication competent oncolytic adenovirus (Telomelysin) for various solid tumors. Mol Ther 18 : 429-434, 2010.
 
13) Matsumoto K, Nakamura T : NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci 94 : 321-327, 2003.
PubMed
14) Oshima Y, et al : Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinoma. Ann Thorac Cardiovasc Surg 16 : 389-393, 2010,
PubMed
15) Yoneyama Y, et al : Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells. Biochem Biophys Res Commun 355 : 129-135, 2007.
PubMed
P.396 掲載の参考文献
1) Starnes CO : Coley's toxins in perspective. Nature 357 : 11-12, 1992.
 
2) Van der Bruggen P, et al : A gene encoding an antigen recognized by cytolytic T lymphocytes on human melanoma. Science 254 : 1643-1647, 1991.
PubMed
3) 田中文明ほか : 樹状細胞と癌抗原ペプチドを用いた進行消化器癌患者に対する癌ワクチン療法-有効な症例とは. Biotherapy 20 : 197-200, 2006.
Medical*Online
4) 定永倫明ほか : MAGEを標的とした消化器癌に対する癌ワクチンの臨床試験. Biotherapy 15 : 182, 2001.
 
5) 唐宇飛, 山名秀明 : 食道癌の治療-食道癌の集学的治療 ; とくに癌免疫療法の現状と展望について-. 消化器外科 27 : 99-105, 2004.
 
6) Jager E, et al : Indiction of primary NY-ESO-1 immunity : CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci USA 97 : 12198-12203, 2000.
 
7) Wada H, et al : Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination. Int J Cancer 123 : 2362-2369, 2008.
PubMed
8) Hasegawa S, et al : Genome-wide analysis of gene expression in intestinal-type gastric cancer using cDNA microarray representing 20340 genes. Cancer Res 62 : 7012-7017, 2002.
 
9) Suda T, et al : Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy. Cancer Sci 98 : 1803-1808, 2007.
PubMed
10) Hayama S, et al : Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res 66 : 10339-10348. 2006.
PubMed
11) Mizukami Y, et al : Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma. Cancer Sci 99 : 1448-1454, 2008.
PubMed
12) Kono K, et al : Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer. Cancer Sci 100 : 1502-1509, 2009.
PubMed
13) U. S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research : Guidance for Industry Clinical Considerations for Therapeutic Cancer Vaccines, Draft Guidance, 2009.
 
14) Niethammer AG, et al : A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 8 : 1369-1375, 2002.
PubMed
15) 金本彰, 田原秀晃 : 抗原ペプチド免疫による消化器癌の免疫療法. Gastrointestinal Research 16 : 10-16, 2008.
Medical*Online
16) Iwahashi M, et al : Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma. Cancer Sci 101 : 2510-2517, 2010.
PubMed
17) 吉田浩二, 中村裕輔 : 消化器癌に対するがんペプチドワクチン療法. 日消誌 107 : 1255-1261, 2010.
 
P.403 掲載の参考文献
1) 幕内博康ほか : m3・sm1食道癌に対するEMRの可能性. 胃と腸 33 : 993-1002, 1998.
 
2) 島田英雄ほか : 治療成績からみた食道m3・sm1癌の治療成績-外科切除例の治療成績 : 3領域郭清の立場から-. 胃と腸 41 : 1429-1440, 2006.
 
3) 門馬久美子ほか : 治療成績からみた食道m3・sm1癌の治療方針. 胃と腸 41 : 1447-1458, 2006.
 
4) Katada C, et al : Local recurrence of squamous-cell carcinoma of the esophagus after EMR. Gastrointest Endosc 61 : 219-225, 2005.
PubMed
5) Esaki M, et al : Risk factor for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy 39 : 41-45, 2007.
PubMed
6) Ishihara R, et al : Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection. Gastrointest Endosc 67 : 799-805, 2008.
PubMed
7) Urabe Y, et al : Metachronous multiple esophageal squamous cell carcinomas and lugol-voiding lesions after endoscopic mucosal resection. Endoscopy 41 : 304-309, 2009.
PubMed
8) 小山恒男ほか : 食道扁平上皮癌に対するESDの成績. 胃と腸 44 : 405-416, 2009.
 
9) 幕内博康 : 胸部食道癌切除術 (開胸法). 手術 60 : 719-725, 2006.
 
10) Osugi H, et al : Video-assisted thoracoscopic esophagectomy and radical lymph node dissection. Surg Endosc 16 : 1588-1593, 2002.
PubMed
11) 能城浩和ほか : 胸部食道癌に対する腹臥位鏡視下食道切除術. 外科診療 100 : 474-481, 2009.
 
12) 桑野博行ほか : 食道癌. 消化器外科 32 : 1017-1027, 2009.
 
13) Toh Y, et al : Follow-up and recurrence after a curative esophagectomy for patients with esophageal cancer : the first indicators for recurrence and their prognostic values. Esophagus 7 : 37-43, 2010.
 
14) Kato H, et al : Classification of recurrent esophageal cancer after radical esophagectomy with two-or three-field lymphadenectomy. Anticancer Res 25 : 3461-3468, 2005.
PubMed
15) 松原久裕ほか : 最近の癌再発の診断法と治療法 I. 食道癌. 2. 治療外科 66 : 256-261, 2004.
 
16) Kato H, et al : Value of positron emission tomography in the diagnosis of oesophageal carcinoma. Br J Surg 91 : 1004-1009, 2004.
PubMed
17) Teyton P, et al : Use of positron emission tomography in surgery follow-up of esophageal cancer. J Gastrointest Surg 13 : 451-458, 2009.
 
18) Ishikura S, et al : Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21 : 2697-2702, 2003.
PubMed
19) Sato Y, et al : A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement. J Am Coll Surg 201 : 188-193, 2005.
 
20) 幕内博康ほか : 食道癌手術症例にみられる他臓器重複癌-EMR症例も含めて. 胃と腸 38 : 317-330, 2003.
 
21) 島田英雄ほか : 食道扁平上皮癌の危険因子および前癌病変. 臨消内科 25 : 279-286, 2010.
 
22) 日本食道学会 (編) : 食道癌診断・治療ガイドライン, 2007年4月版, 金原出版, 2007.
 
23) Stahl M, et al : Esophageal cancer : clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21 (Suppl 5) : v46-v49, 2010.
 
24) Ajani JA, et al : Esophageal cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 6 : 818-849, 2008.
PubMed

IX 食道癌の再発とその治療

P.413 掲載の参考文献
1) 日本食道学会 (編) : 食道癌診断・治療ガイドライン, 2007.
 
2) 石原立ほか : 食道m1・m2癌EMR後の長期成績. 胃と腸 42 : 1309-1315, 2007.
 
3) 門馬久美子ほか : EMR後の局所再発と合併症対策-食道m1～m3癌の治療成績から. 消化器内視鏡 15 : 365-370, 2003.
 
4) 小山恒男ほか : 内視鏡的食道粘膜切除後の局所再発. 胃と腸 31 : 1217-1222, 1996.
 
5) 北村陽子ほか : 食道m1・m2癌ESD後の経過. 胃と腸 42 : 1323-1329, 2007.
 
6) 幕内博康ほか : 食道癌治療の最前線-早期食道癌の内視鏡的治療. 外科 57 : 1027-1031, 1995.
 
7) 有馬美和子ほか : 食道m3・sm1癌内視鏡切除後の経過. 胃と腸 42 : 1331-1340, 2007.
 
P.418 掲載の参考文献
1) Nakagawa S, et al : Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 198 : 205-211, 2004.
PubMed
2) Kato H, et al : Classification of recurrent esophageal cancer after radical esophagectomy with two-or three-field lymphadenectomy. Anticancer Res 25 : 3461-3468, 2005.
PubMed
3) Kunisaki C, et al : Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy. J Gastrointest Surg 12 : 802-810, 2008.
PubMed
4) Natsugoe S, et al : Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer. Langenbecks Arch Surg 395 : 341-346, 2010.
PubMed
5) 松原久裕, 落合武徳 : 再発治療からみた食道癌術後患者のフォローアップ. 臨床外科 57 : 751-757, 2002.
 
6) 篠田雅幸ほか : 食道がん治療のプロトコール. 臨床外科 60 : 7-14, 2005.
 
7) 白川靖博ほか : 再発食道癌治療の変遷とその成績-PET-CT導入で何が変わったか-. 癌と化学療法 36 : 2465-2467, 2009.
Medical*Online
P.426 掲載の参考文献
1) Herskovic A, et al : Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (24) : 1593-1598, 1992.
PubMed
2) Ishida K, et al : Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus : aJapan Esophageal Oncology Group (JEOG) / Japan Clinical Oncology Group Trial (JCOG9516). Jpn J Clin Oncol 34 (10) : 615-619, 2004.
 
3) Kato H, et al : A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma : Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 39 (10) : 638-643, 2009.
 
4) Kato K, et al : Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma : JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys, 2010. (in press)
 
5) Geh JI : The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 38 (2) : 300-313, 2002.
PubMed
6) Richmond J, et al : Comparison of three treatment strategies for esophageal cancer within a single institute. Int J Radiat Oncol Biol Phys 13 : 1617-1620, 1987.
PubMed
7) John MJ, et al : Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. Cancer 63 : 2397-2403, 1989.
PubMed
8) Al-Sarraf M, et al : Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer : an intergroup study. J Clin Oncol 15 (1) : 277-284, 1997.
PubMed
9) Reddy SP, et al : Radiotherapy alone compared with radiotherapy and chemotherapy in patients with squamous cell carcinoma of the esophagus. Am J Clin Oncol 18 : 376-381, 1995.
PubMed
10) Minsky BD, et al : Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12) : Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43 (3) : 517-523, 1999.
PubMed
11) Minsky DM, et al : INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer. J Clin Oncol 20 (5) : 1167-1174, 2002.
 
12) Zhang Z, et al : Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61 : 656-664, 2005.
PubMed
13) Liao Z, et al : Esophagectomy after concurrent chemo-radiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60 : 1484-1493, 2004.
PubMed

X 食道癌のQOL

P.437 掲載の参考文献
1) 外村修一, 小西敏郎 : 食道癌のクリニカルパス. 外科 63 : 453-456, 2001.
 
2) 奈良智之, 小西敏郎 : 食道癌手術のクリニカルパス. 臨床外科 58 : 83-90, 2003,
 
3) 外村修一ほか : 胸部食道癌に対する胸腔内による再建術式. 手術 55 : 981-988, 2001.
 
4) 奈良智之ほか : 癌治療クリニカルパスUpdate・食道癌手術. 外科治療 99 : 8-12, 2008.
 
P.442 掲載の参考文献
1) 赤永尚史 : がん悪液質の病態. 静脈経腸栄養 23 (4) : 607-611, 2008.
 
2) Laviano A, Meguid MM : Nutritional issues in cancer management. Nutrition 12 (5) : 358-371, 1996.
PubMed
3) Weimann A, et al : ESPEN Guidelines on Enteral Nutrition : Surgery including organ transplantation. Clin Nutr 25 (2) : 224-244, 2006.
PubMed
4) August DA, Huhmann MB ; American Society for Parenteral and Enteral Nutrition (A. S. P. E. N.) Board of Directors : A. S. P. E. N. clinical guidelines : nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr 33 (5) : 472-500, 2009.
 
5) Braga M, et al : ESPEN Guidelines on Parenteral Nutrition : surgery. Clin Nutr 28 (4) : 378-386, 2009.
PubMed
6) Singer P, et al : ESPEN Guidelines on Parenteral Nutrition : intensive care. Clin Nutr 28 (4) : 387-400, 2009.
PubMed
7) Ryan AM, et al : Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery : results of a double-blinded randomized controlled trial. Ann Surg 249 (3) : 355-363, 2009.
PubMed
8) van den Berghe G, et al : Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (19) : 1359-1367, 2001.
 
9) Preiser JC, et al : A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units : the Glucontrol study. Intensive Care Med 35 (10) : 1738-1748, 2009.
PubMed
10) Yamamoto K, et al : Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery 148 (1) : 31-38, 2010.
PubMed
11) Ohnmacht GA, et al : Percutaneous endoscopic gastrostomy risks rendering the gastric conduit unusable for esophagectomy. Dis Esophagus 19 (4) : 311-312, 2006.
 
12) Langer FB, et al : Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol 17 (2) : 470-475, 2010.
PubMed
13) Martin L, et al : Malnutrition after oesophageal cancer surgery in Sweden. Br J Surg 94 (12) : 1496-1500, 2007.
PubMed
14) Martin L, et al : The infiuence of needle catheter jejunostomy on weight development after oesophageal cancer surgery in a population-based study. Eur J Surg Oncol 33 (6) : 713-717, 2007.
 
15) Martin L, et al : Risk factors for malnutrition after oesophageal and cardia cancer surgery. Br J Surg 95 (11) : 1362-1368, 2008.
PubMed
P.448 掲載の参考文献
1) Gussenbauer C : Uber die erste durch Th. Billroth am Menschen ausgefuhrte Kehlkopf-Exstirpation und die Anwendung eines Kunstlichen Kehlkopfes. Arch Klin Chir 17 : 343-356, 1874.
 
2) 廣瀬肇ほか : 食道発声法による語音調節 : 有声, 無声の弁別を中心に. 音声言語医学 24 : 197-203, 1983.
 
3) Singer MI, Blom ED : An endoscopic technique for restoration of voice after laryngectomy. Ann Otol 89 : 529-533, 1980.
PubMed
4) Hilgers FJ : Development and clinical evaluation of a second-generation voice prosthesis (Provox 2), designed for anterograde and retrograde insertion. Acta Otolaryngol 117 : 889-896, 1997.
PubMed
5) Conley JJ, et al : A new surgical technique for the vocal rehabilitation of the laryngectomized patient. Ann Otol Rhinol Laryngol 67 : 655-664, 1958.
PubMed
6) 天津睦郎ほか : 喉摘後の音声獲得手術 ; one stageで行う新しい術式について. 日耳鼻会報 80 : 779-785, 1977.
 
7) Asai R : Laryngoplasty after total laryngectomy. Arch Otolaryngol 95 : 114-119, 1972.
PubMed
8) Ehrenberger K et al : Jejunal grafts for reconstructing a phonatory neoglottis in laryngectomized patients. Arch Otorhinolaryngol 242 : 217-223, 1985.
PubMed
9) 野崎幹広ほか : 遊離腸管による咽喉食摘後の食道音声同時再建. 頭頸部腫瘍 23 : 547-552, 1997.
 
10) 川原英之ほか : 喉頭全摘後の音声再獲得を目的とした遊離回盲部移植による頸部食道再建術. 手術 43 : 1377-1388, 1989.
 
11) Kinishi M, et al : Primary tracheojejunal shunt operation for voice restoration following pharyngolaryngoesophagectomy. Ann Otol Rhinol Laryngol 100 : 435-438, 1991.
PubMed
12) 斉藤等ほか : 下咽頭頸部食道癌摘出後の胃管による再建とT-Gシャントによる発声手術. 耳喉 53 : 1137-1142, 1981.
 
13) 池内駿之ほか : 咽喉食摘患者に対する下部食道噴門管挙上による音声再建. 日気管食道会報 44 : 90-95, 1993.
 
14) 藤枝重治ほか : 高齢者の喉頭全摘音声再建. 喉頭 12 : 79 -83, 2000.
 
15) 天津睦郎ほか : 高齢者の頭頸部悪性腫瘍 (2) 高齢者の喉頭下咽頭癌. 耳喉頭頸 70 (増刊) : 129-134, 1998.
 

XI 食道癌の多施設共同試験

P.456 掲載の参考文献
1) Shimoyama M, et al : Japan Clinical Oncology Group (JCOG). Jpn J Clin Oncol 28 : 158-162, 1998.
PubMed
2) 赤倉一郎, 中村嘉三 : 食道癌の治療について. 慶應医学 44 : 665-674, 1967.
 
3) 中山恒明ほか : 食道癌の術前照射について. 外科 22 : 325-328, 1960.
 
4) Akakura I, et al : Surgery of carcinoma of the esophagus with preoperative radiation. Chest 57 : 47-57, 1970.
PubMed
5) Cooperative Clinical Study Group for Esophageal Carcinoma : Multidisciplinary treatment for esophageal carcinoma. Jpn J Clin Oncol 13 : 417-424, 1983.
 
6) Kasai M : Surgical treatment for carcinoma of the esophagus. J Jpn Surg Soc 81 : 845-853, 1980.
 
7) Iizuka T, et al : Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest 93 : 1054-1058, 1988.
PubMed
8) Japanese Esophageal Oncology Group : A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma, Chest 104 : 203-207, 1993.
 
9) Ando N, et al : A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus : The Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 114 : 205-209, 1997.
 
10) Ando N, et al : Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232 : 225-232, 2000.
PubMed
11) Ando N, et al : Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus : a Japan Clinical Oncology Group Study-JCOG 9204. J Clin Oncol 24 : 4592-4596, 2003.
 
12) Iizuka T, et al : Phase II evaluation of cisplatin and vindesine in advanced squamous cell carcinoma of the esophagus : Japan Esophageal Oncology Group Trial. Jpn J Clin Oncol 21 : 176-179, 1991.
 
13) Iizuka T, et al : Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus : Japan Esophageal Oncology Group Trial. Jpn J Clin Oncol 22 : 172-176, 1992.
 
14) Ando N, et al : A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for localized squamous cell carcinoma of the thoracic esophagus (JCOG 9907). Proc 2008 Gastrointestinal Cancers Symposium.
 
15) Igaki H, et al : A randomized trial of postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/III squamous cell carcinoma of the thoracic esophagus (JCOG 9907). Proc Am Soc Clin Oncol 26 : 215s, 2008.
 
16) Al-Sarraf M, et al : Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer : An intergroup study. J Clin Oncol 15 : 277-284, 1997.
PubMed
17) Ishida K, et al : Phase II Study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus : a Japan Esophageal Oncology Group (JEOG) / Japan Clinical Oncology Group Trial (JCOG9516). Jpn J Clin Oncol 34 : 615-619, 2004.
PubMed
18) Ohtsu A, et al : Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17 : 2915-2921, 1999.
 
19) Kato H, et al : A phase II trial of chemo-radiotherapy in patients with stage I esophageal squamous cell carcinoma : Japan Clinical Oncology Group study (JCOG 9708). Proc Am Soc Clin Oncol 22 : 286, 2003.
 
20) Igaki H, et al : Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinoma of the thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 20 : 1089-1094, 2000.
 
21) Minashi K, et al : A phase II study of chemoradiotherapy in patients with stage II, III esophageal squamous cell carcinoma (ESSC) : JCOG trial (JCOG9906). Proc 2008 Gastrointestinal Cancers Symposium.
 
P.463 掲載の参考文献
1) Inoue H, et al : Ultra-high magnification endoscopic observation of carcinoma in situ of the esophagus. Dig Endosc 9 : 16-18, 1997.
 
2) 有馬秀明 : 食道粘膜の拡大観察による検討. Gastrointestinal Endoscopy 40 (8) : 1125-1137, 1998.
 
3) Gono T, et al : Endoscopic observation of tissue by narrow band illumination. Optic Rev 10 : 211-215, 2003.
 
4) 佐野寧ほか : 狭帯域RGB filter内蔵narrow band imaging (NBI) systemの開発・臨床応用. 胃と腸 36 : 1283-1287, 2001.
 
5) 有馬美和子ほか : FICEを併用した拡大内視鏡による表在食道病変の微細血管診断. 日気管食道会報 35 : 24-28, 2007.
 
6) Yokoyama T, et al : Alcohol flusing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol Biomarkers Prev 12 : 1227-1233, 2003.
 
7) Muto M, et al : Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region. Carcinogenesis 26 (5) : 1008-1012, 2005.
PubMed
8) Secretan B, et al : A review of human carcinogens-Part E : tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10 (11) : 1033-1034, 2009.
PubMed
9) Slaughter DP, et al : Field cancerization in oral stratified squamous epithelium : clinical implications of multicentric origin. Cancer 6 : 963-968, 1953.
PubMed
10) Muto M, et al : Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer 101 : 1375-1381, 2004.
PubMed
11) 有馬美和子ほか : 食道表在癌の深達度診断-FICE拡大内視鏡の立場から. 胃と腸 45 : 1515-1525, 2010.
 
12) Bossuyt PM, et al : Towards complete and accurate reporting of studies of diagnostic accuracy : the STARD initiative. BMJ 326 : 41-44, 2003.
PubMed
13) Muto M, et al : Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging : A multicenter randomized controlled trial. J Clin Oncol 28 : 1566-1572, 2010.
PubMed
14) Muto M, et al : Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 56 (4) : 517-521, 2002.
PubMed
P.468 掲載の参考文献
1) Kelsen DP, et al : Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 : 1979-1984, 1998.
PubMed
2) Medical Research Council Oesophageal Cancer Working Group : Surgical resection with or without preoperative chemotherapy in oesophageal cancer : a randomised controlled trial. Lancet 359 : 1727-1733, 2002.
PubMed
3) Gebski V, et al : Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma : a meta-analysis. Lancet Oncol 8 : 226-234, 2007.
 
4) Bosset JF, et al : Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 : 161-167, 1997.
PubMed
5) Burmeister BH, et al : Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus : a randomised controlled phase III trial. Lancet Oncol 6 : 659-668, 2005.
PubMed
6) Tepper J, et al : Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer : CALGB9781. J Clin Oncol 26 : 1086-1092, 2008.
 
7) Mariette C, et al : Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer : Analysis of a randomized controlled phase III trial FFCD9901. J Clin Oncol 28 : 15s, 2010.
 
8) Smith TJ, et al : Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus : a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42 : 269-276, 1998.
PubMed
9) Herskovic A, et al : Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 : 1593-1598, 1992.
PubMed
10) al-Sarraf M, et al : Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer : an intergroup study. J Clin Oncol 15 : 277-284, 1997.
PubMed
11) Minsky BD, et al : INT0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer : high-dose versus standard-dose radiation therapy. J Clin Oncol 20 : 1167-1174, 2002.
 
12) Minsky BD, et al : Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG90-12) : Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 43 : 517-523, 1999.
PubMed

XII 特論

P.474 掲載の参考文献
1) Baile WF, et al : SPIKES-A six-step protocol for delivering bad news : application to the patient with cancer. Oncologist 5 (4) : 302-311, 2000.
 
2) 内富庸介ほか : がんに対する反応. サイコオンコロジー (山脇成人監), p9-19, 診療新社, 1997.
 
3) 笹子三津留 : 癌の告知-告知を受けた患者へのアンケート調査報告. 医学のあゆみ 160 : 146-151, 1992.
 
4) 永田靖ほか : 放射線治療におけるインフォームドコンセント. 臨牀と研究 77 : 88-93, 2000.
 
5) Ishikura S, et al : Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21 : 2697-2702, 2003.
PubMed
6) Igaki H, et al : A randomized controlled trial of chemotherapy with 5FU and cisplatin before and after surgery for stage II, III squamous cell carcinoma of the thoracic esophagus (JCOG9907). J Clin Oncol 26 : abstr 4510, 2008.
 
P.483 掲載の参考文献
1) 幕内博康ほか : 食道集検について-慶応がんセンター発見例および全国集計の分析と食道集検成立可否の検討. 日消集検誌 57 : 5-12, 1982.
 
2) 細井董三ほか : 集検における食道粘膜癌の拾いあげの実態と問題点. 消化器内視鏡 2 : 453-459, 1990.
 
3) 細井董三ほか : 早期食道癌の診断 (1) X線診断の進歩の現状. 臨床消化器内科 12 : 1695-1704, 1997.
 
4) 細井董三ほか : 間接食道集検における早期食道癌の拾い上げ胃と腸 32 : 1289-1297, 1997.
 
5) 細井董三ほか : 食道表在癌のスクリーニング. 消化器外科 22 : 283-288, 1999.
 
6) 細井董三ほか : 1. 食道癌の深達度診断. 1) 二重造影像からみた深達度診断. 胃と腸 36 : 283-294, 2001.
 
7) 入口陽介ほか : 間接食道・胃同時集検の成果と問題点. Tama Symposium Journal of Gastroenterology 15 : 30-36, 2001.
 
8) 細井董三ほか : 食道表在癌のX線診断-拾い上げ診断と深達度診断-. 外科 63 : 403-413, 2001.
 
9) 小田丈二ほか : 検診診断のポイント 食道. 臨床画像 19 : 299-306, 2003.
 
10) 小田丈二, 細井董三 : 食道がん検診および診療の実際. 老年消化器病 18 : 7-12, 2007,
 
11) 小田丈二ほか : 食道表在癌のX線診断-X線集団検診による食道表在癌の拾い上げと精密X線における側面変形による深達度診断の有用性-. 臨床消化器内科 25 : 769-779, 2010.
 
12) 大森泰ほか : 集検による食道癌の早期診断. 食道表在癌-画像診断と病理 (吉田操ほか編), p58-61, 医学書院,1993.
 
P.490 掲載の参考文献
1) 松田晋也 : 基礎から読み解くDPC, p24-29, 医学書院, 2005.
 
2) DPC点数早見表2010年4月版, p122-123, 医学通信社, 2010.
 
3) 池田俊也 : クリティカルパス最近の進歩 (1) DPCとクリティカルパス-DPC対応型クリティカルパスの5つの条件-. 医療マネジメント会誌 5 : 358-360, 2004.
 
P.494 掲載の参考文献
1) 日本食道学会 (編) : 食道癌診断・治療ガイドライン2007年4月版, 金原出版, 2007.
 
2) 小山恒男, 宮田佳典, 島谷茂樹ほか : 第46回食道色素研究会アンケート調査報告-転移のあったm3・sm1食道癌の特徴. 胃と腸 37 : 71-74, 2002.
 
3) Fujishiro M, Yahagi N, Kakushima M, et al : Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol 4 : 688-694, 2006.
 
4) Ono S, Fujishiro M, Niimi K, et al : Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms. Endoscopy 41 : 661-665, 2009.
PubMed
5) Saito Y, Tanaka T, Andoh A, et al : Endoscopic submucosal dissection of recurrent or residual superficial esophageal cancer after chemoradiotherapy. Gastrointest Endosc 67 : 355-359, 2008.
 
6) Ezoe Y, Muto M, Horimatsu T, et al : Efficacy of preventive endoscopic balloon dilatation for esophageal stricture after endoscopic resection. J Clin Gastroenterol 45 : 222-227, 2011.
PubMed
7) 永原章仁, 光永篤, 藤崎順子ほか : 費用対効果比からみたESDの存在意義-第15回EGMR研究会-ESDの処置具, 薬剤の使用実態アンケート結果より. 消化器内視鏡 20 : 275-281, 2008.
Medical*Online
8) 島田英雄, 幕内博康, 千野修ほか : 早期食道癌. 外科 71 : 469-474, 2009.
 

書評

最近チェックした商品履歴

Loading...